The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
Identifieur interne : 000093 ( Pmc/Checkpoint ); précédent : 000092; suivant : 000094The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
Auteurs : Tianhong Pan [États-Unis] ; Julie Zhu [États-Unis] ; Wen Hwu [États-Unis] ; Joseph Jankovic [États-Unis]Source :
- PLoS ONE ; 2012.
Abstract
The relatively high co-occurrence of Parkinson’s disease (PD) and melanoma has been established by a large number of epidemiological studies. However, a clear biological explanation for this finding is still lacking. Ultra-violet radiation (UVR)-induced skin melanin synthesis is a defense mechanism against UVR-induced damage relevant to the initiation of melanoma, whereas, increased neuromelanin (NM), the melanin synthesized in dopaminergic neurons, may enhance the susceptibility to oxidative stress-induced neuronal injury relevant to PD.
Url:
DOI: 10.1371/journal.pone.0045183
PubMed: 23028833
PubMed Central: 3446957
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:3446957Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells</title>
<author><name sortKey="Pan, Tianhong" sort="Pan, Tianhong" uniqKey="Pan T" first="Tianhong" last="Pan">Tianhong Pan</name>
<affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhu, Julie" sort="Zhu, Julie" uniqKey="Zhu J" first="Julie" last="Zhu">Julie Zhu</name>
<affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hwu, Wen Jen" sort="Hwu, Wen Jen" uniqKey="Hwu W" first="Wen" last="Hwu">Wen Hwu</name>
<affiliation wicri:level="2"><nlm:aff id="aff2"><addr-line>Melanoma Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Melanoma Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff3"><addr-line>Parkinson’s Disease Center and Movement Disorder Clinic, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson’s Disease Center and Movement Disorder Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23028833</idno>
<idno type="pmc">3446957</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446957</idno>
<idno type="RBID">PMC:3446957</idno>
<idno type="doi">10.1371/journal.pone.0045183</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000289</idno>
<idno type="wicri:Area/Pmc/Curation">000289</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000093</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells</title>
<author><name sortKey="Pan, Tianhong" sort="Pan, Tianhong" uniqKey="Pan T" first="Tianhong" last="Pan">Tianhong Pan</name>
<affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhu, Julie" sort="Zhu, Julie" uniqKey="Zhu J" first="Julie" last="Zhu">Julie Zhu</name>
<affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hwu, Wen Jen" sort="Hwu, Wen Jen" uniqKey="Hwu W" first="Wen" last="Hwu">Wen Hwu</name>
<affiliation wicri:level="2"><nlm:aff id="aff2"><addr-line>Melanoma Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Melanoma Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff3"><addr-line>Parkinson’s Disease Center and Movement Disorder Clinic, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson’s Disease Center and Movement Disorder Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">PLoS ONE</title>
<idno type="e-ISSN">1932-6203</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The relatively high co-occurrence of Parkinson’s disease (PD) and melanoma has been established by a large number of epidemiological studies. However, a clear biological explanation for this finding is still lacking. Ultra-violet radiation (UVR)-induced skin melanin synthesis is a defense mechanism against UVR-induced damage relevant to the initiation of melanoma, whereas, increased neuromelanin (NM), the melanin synthesized in dopaminergic neurons, may enhance the susceptibility to oxidative stress-induced neuronal injury relevant to PD. <italic>SNCA</italic>
is a PD-causing gene coding for alpha-Synuclein (α-Syn) that expresses not only in brain, but also in skin as well as in tumors, such as melanoma. The findings that α-Syn can interact with tyrosinase (TYR) and inhibit tyrosine hydroxylase (TH), both of which are enzymes involved in the biosynthesis of melanin and dopamine (DA), led us to propose that α-Syn may participate in the regulation of melanin synthesis. In this study, by applying ultraviolet B (UVB) light, a physiologically relevant stimulus of melanogenesis, we detected melanin synthesis in A375 and SK-MEL-28 melanoma cells and in SH-SY5Y and PC12 dopaminergic neuronal cells and determined effects of α-Syn on melanin synthesis. Our results showed that UVB light exposure increased melanin synthesis in all 4 cell lines. However, we found that α-Syn expression reduced UVB light-induced increase of melanin synthesis and that melanin content was lower when melanoma cells were expressed with α-Syn, indicating that α-Syn may have inhibitory effects on melanin synthesis in melanoma cells. Different from melanoma cells, the melanin content was higher in α-Syn-over-expressed dopaminergic neuronal SH-SY5Y and PC12 cells, cellular models of PD, than that in non-α-Syn-expressed control cells. We concluded that α-Syn could be one of the points responsible for the positive association between PD and melanoma via its differential roles in melanin synthesis in melanoma cells and in dopaminergic neuronal cells.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Liu, R" uniqKey="Liu R">R Liu</name>
</author>
<author><name sortKey="Gao, X" uniqKey="Gao X">X Gao</name>
</author>
<author><name sortKey="Lu, Y" uniqKey="Lu Y">Y Lu</name>
</author>
<author><name sortKey="Chen, H" uniqKey="Chen H">H Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bertoni, Jm" uniqKey="Bertoni J">JM Bertoni</name>
</author>
<author><name sortKey="Arlette, Jp" uniqKey="Arlette J">JP Arlette</name>
</author>
<author><name sortKey="Fernandez, Hh" uniqKey="Fernandez H">HH Fernandez</name>
</author>
<author><name sortKey="Fitzer Attas, C" uniqKey="Fitzer Attas C">C Fitzer-Attas</name>
</author>
<author><name sortKey="Frei, K" uniqKey="Frei K">K Frei</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ferreira, Jj" uniqKey="Ferreira J">JJ Ferreira</name>
</author>
<author><name sortKey="Neutel, D" uniqKey="Neutel D">D Neutel</name>
</author>
<author><name sortKey="Mestre, T" uniqKey="Mestre T">T Mestre</name>
</author>
<author><name sortKey="Coelho, M" uniqKey="Coelho M">M Coelho</name>
</author>
<author><name sortKey="Rosa, Mm" uniqKey="Rosa M">MM Rosa</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gao, X" uniqKey="Gao X">X Gao</name>
</author>
<author><name sortKey="Simon, Kc" uniqKey="Simon K">KC Simon</name>
</author>
<author><name sortKey="Han, J" uniqKey="Han J">J Han</name>
</author>
<author><name sortKey="Schwarzschild, Ma" uniqKey="Schwarzschild M">MA Schwarzschild</name>
</author>
<author><name sortKey="Ascherio, A" uniqKey="Ascherio A">A Ascherio</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Driver, Ja" uniqKey="Driver J">JA Driver</name>
</author>
<author><name sortKey="Logroscino, G" uniqKey="Logroscino G">G Logroscino</name>
</author>
<author><name sortKey="Buring, Je" uniqKey="Buring J">JE Buring</name>
</author>
<author><name sortKey="Gaziano, Jm" uniqKey="Gaziano J">JM Gaziano</name>
</author>
<author><name sortKey="Kurth, T" uniqKey="Kurth T">T Kurth</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Pan, T" uniqKey="Pan T">T Pan</name>
</author>
<author><name sortKey="Li, X" uniqKey="Li X">X Li</name>
</author>
<author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Plun Favreau, H" uniqKey="Plun Favreau H">H Plun-Favreau</name>
</author>
<author><name sortKey="Lewis, Pa" uniqKey="Lewis P">PA Lewis</name>
</author>
<author><name sortKey="Hardy, J" uniqKey="Hardy J">J Hardy</name>
</author>
<author><name sortKey="Martins, Lm" uniqKey="Martins L">LM Martins</name>
</author>
<author><name sortKey="Wood, Nw" uniqKey="Wood N">NW Wood</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Paisan Ruiz, C" uniqKey="Paisan Ruiz C">C Paisán-Ruiz</name>
</author>
<author><name sortKey="Houlden, H" uniqKey="Houlden H">H Houlden</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Inzelberg, R" uniqKey="Inzelberg R">R Inzelberg</name>
</author>
<author><name sortKey="Israeli Korn, Sd" uniqKey="Israeli Korn S">SD Israeli-Korn</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Inzelberg, R" uniqKey="Inzelberg R">R Inzelberg</name>
</author>
<author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Izykowska, I" uniqKey="Izykowska I">I Izykowska</name>
</author>
<author><name sortKey="Gebarowska, E" uniqKey="Gebarowska E">E Gebarowska</name>
</author>
<author><name sortKey="Cegielski, M" uniqKey="Cegielski M">M Cegielski</name>
</author>
<author><name sortKey="Podhorska Okolow, M" uniqKey="Podhorska Okolow M">M Podhorska-Okolow</name>
</author>
<author><name sortKey="Piotrowska, A" uniqKey="Piotrowska A">A Piotrowska</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gilchrest, Ba" uniqKey="Gilchrest B">BA Gilchrest</name>
</author>
<author><name sortKey="Eller, Ms" uniqKey="Eller M">MS Eller</name>
</author>
<author><name sortKey="Geller, Ac" uniqKey="Geller A">AC Geller</name>
</author>
<author><name sortKey="Yaar, M" uniqKey="Yaar M">M Yaar</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jiang, W" uniqKey="Jiang W">W Jiang</name>
</author>
<author><name sortKey="Ananthaswamy, Hn" uniqKey="Ananthaswamy H">HN Ananthaswamy</name>
</author>
<author><name sortKey="Muller, Hk" uniqKey="Muller H">HK Muller</name>
</author>
<author><name sortKey="Kripke, Ml" uniqKey="Kripke M">ML Kripke</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Harbour, Jw" uniqKey="Harbour J">JW Harbour</name>
</author>
<author><name sortKey="Brantley, Ma" uniqKey="Brantley M">MA Brantley</name>
</author>
<author><name sortKey="Hollingsworth, H" uniqKey="Hollingsworth H">H Hollingsworth</name>
</author>
<author><name sortKey="Gordon, M" uniqKey="Gordon M">M Gordon</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Dwyer, T" uniqKey="Dwyer T">T Dwyer</name>
</author>
<author><name sortKey="Blizzard, L" uniqKey="Blizzard L">L Blizzard</name>
</author>
<author><name sortKey="Ashbolt, R" uniqKey="Ashbolt R">R Ashbolt</name>
</author>
<author><name sortKey="Plumb, J" uniqKey="Plumb J">J Plumb</name>
</author>
<author><name sortKey="Berwick, M" uniqKey="Berwick M">M Berwick</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Aitken, Jf" uniqKey="Aitken J">JF Aitken</name>
</author>
<author><name sortKey="Elwood, Jm" uniqKey="Elwood J">JM Elwood</name>
</author>
<author><name sortKey="Lowe, Jb" uniqKey="Lowe J">JB Lowe</name>
</author>
<author><name sortKey="Firman, Dw" uniqKey="Firman D">DW Firman</name>
</author>
<author><name sortKey="Balanda, Kp" uniqKey="Balanda K">KP Balanda</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Weinstock, Ma" uniqKey="Weinstock M">MA Weinstock</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wright Willis, A" uniqKey="Wright Willis A">A Wright Willis</name>
</author>
<author><name sortKey="Evanoff, Ba" uniqKey="Evanoff B">BA Evanoff</name>
</author>
<author><name sortKey="Lian, M" uniqKey="Lian M">M Lian</name>
</author>
<author><name sortKey="Criswell, Sr" uniqKey="Criswell S">SR Criswell</name>
</author>
<author><name sortKey="Racette, Ba" uniqKey="Racette B">BA Racette</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Dahodwala, N" uniqKey="Dahodwala N">N Dahodwala</name>
</author>
<author><name sortKey="Siderowf, A" uniqKey="Siderowf A">A Siderowf</name>
</author>
<author><name sortKey="Xie, M" uniqKey="Xie M">M Xie</name>
</author>
<author><name sortKey="Noll, E" uniqKey="Noll E">E Noll</name>
</author>
<author><name sortKey="Stern, M" uniqKey="Stern M">M Stern</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Elbaz, A" uniqKey="Elbaz A">A Elbaz</name>
</author>
<author><name sortKey="Moisan, F" uniqKey="Moisan F">F Moisan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Shulman, Jm" uniqKey="Shulman J">JM Shulman</name>
</author>
<author><name sortKey="De Jager, Pl" uniqKey="De Jager P">PL De Jager</name>
</author>
<author><name sortKey="Feany, Mb" uniqKey="Feany M">MB Feany</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Singleton, Ab" uniqKey="Singleton A">AB Singleton</name>
</author>
<author><name sortKey="Farrer, M" uniqKey="Farrer M">M Farrer</name>
</author>
<author><name sortKey="Johnson, J" uniqKey="Johnson J">J Johnson</name>
</author>
<author><name sortKey="Singleton, A" uniqKey="Singleton A">A Singleton</name>
</author>
<author><name sortKey="Hague, S" uniqKey="Hague S">S Hague</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Polymeropoulos, Mh" uniqKey="Polymeropoulos M">MH Polymeropoulos</name>
</author>
<author><name sortKey="Lavedan, C" uniqKey="Lavedan C">C Lavedan</name>
</author>
<author><name sortKey="Leroy, E" uniqKey="Leroy E">E Leroy</name>
</author>
<author><name sortKey="Ide, Se" uniqKey="Ide S">SE Ide</name>
</author>
<author><name sortKey="Dehejia, A" uniqKey="Dehejia A">A Dehejia</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Shishido, T" uniqKey="Shishido T">T Shishido</name>
</author>
<author><name sortKey="Ikemura, M" uniqKey="Ikemura M">M Ikemura</name>
</author>
<author><name sortKey="Obi, T" uniqKey="Obi T">T Obi</name>
</author>
<author><name sortKey="Yamazaki, K" uniqKey="Yamazaki K">K Yamazaki</name>
</author>
<author><name sortKey="Terada, T" uniqKey="Terada T">T Terada</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wakabayashi, K" uniqKey="Wakabayashi K">K Wakabayashi</name>
</author>
<author><name sortKey="Mori, F" uniqKey="Mori F">F Mori</name>
</author>
<author><name sortKey="Tanji, K" uniqKey="Tanji K">K Tanji</name>
</author>
<author><name sortKey="Orimo, S" uniqKey="Orimo S">S Orimo</name>
</author>
<author><name sortKey="Takahashi, H" uniqKey="Takahashi H">H Takahashi</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ikemura, M" uniqKey="Ikemura M">M Ikemura</name>
</author>
<author><name sortKey="Saito, Y" uniqKey="Saito Y">Y Saito</name>
</author>
<author><name sortKey="Sengoku, R" uniqKey="Sengoku R">R Sengoku</name>
</author>
<author><name sortKey="Sakiyama, Y" uniqKey="Sakiyama Y">Y Sakiyama</name>
</author>
<author><name sortKey="Hatsuta, H" uniqKey="Hatsuta H">H Hatsuta</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Luk, Kc" uniqKey="Luk K">KC Luk</name>
</author>
<author><name sortKey="Kehm, Vm" uniqKey="Kehm V">VM Kehm</name>
</author>
<author><name sortKey="Zhang, B" uniqKey="Zhang B">B Zhang</name>
</author>
<author><name sortKey="O Rien, P" uniqKey="O Rien P">P O’Brien</name>
</author>
<author><name sortKey="Trojanowski, Jq" uniqKey="Trojanowski J">JQ Trojanowski</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Olanow, Cw" uniqKey="Olanow C">CW Olanow</name>
</author>
<author><name sortKey="Prusiner, Sb" uniqKey="Prusiner S">SB Prusiner</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bruening, W" uniqKey="Bruening W">W Bruening</name>
</author>
<author><name sortKey="Giasson, Bi" uniqKey="Giasson B">BI Giasson</name>
</author>
<author><name sortKey="Klein Szanto, Aj" uniqKey="Klein Szanto A">AJ Klein-Szanto</name>
</author>
<author><name sortKey="Lee, Vm" uniqKey="Lee V">VM Lee</name>
</author>
<author><name sortKey="Trojanowski, Jq" uniqKey="Trojanowski J">JQ Trojanowski</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ye, Q" uniqKey="Ye Q">Q Ye</name>
</author>
<author><name sortKey="Wang, Tf" uniqKey="Wang T">TF Wang</name>
</author>
<author><name sortKey="Peng, Yf" uniqKey="Peng Y">YF Peng</name>
</author>
<author><name sortKey="Xie, J" uniqKey="Xie J">J Xie</name>
</author>
<author><name sortKey="Feng, B" uniqKey="Feng B">B Feng</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Matsuo, Y" uniqKey="Matsuo Y">Y Matsuo</name>
</author>
<author><name sortKey="Kamitani, T" uniqKey="Kamitani T">T Kamitani</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Peng, X" uniqKey="Peng X">X Peng</name>
</author>
<author><name sortKey="Tehranian, R" uniqKey="Tehranian R">R Tehranian</name>
</author>
<author><name sortKey="Dietrich, P" uniqKey="Dietrich P">P Dietrich</name>
</author>
<author><name sortKey="Stefanis, L" uniqKey="Stefanis L">L Stefanis</name>
</author>
<author><name sortKey="Perez, Rg" uniqKey="Perez R">RG Perez</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Perez, Rg" uniqKey="Perez R">RG Perez</name>
</author>
<author><name sortKey="Waymire, Jc" uniqKey="Waymire J">JC Waymire</name>
</author>
<author><name sortKey="Lin, E" uniqKey="Lin E">E Lin</name>
</author>
<author><name sortKey="Liu, Jj" uniqKey="Liu J">JJ Liu</name>
</author>
<author><name sortKey="Guo, F" uniqKey="Guo F">F Guo</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ando, H" uniqKey="Ando H">H Ando</name>
</author>
<author><name sortKey="Kondoh, H" uniqKey="Kondoh H">H Kondoh</name>
</author>
<author><name sortKey="Ichihashi, M" uniqKey="Ichihashi M">M Ichihashi</name>
</author>
<author><name sortKey="Hearing, Vj" uniqKey="Hearing V">VJ Hearing</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Tessari, I" uniqKey="Tessari I">I Tessari</name>
</author>
<author><name sortKey="Bisaglia, M" uniqKey="Bisaglia M">M Bisaglia</name>
</author>
<author><name sortKey="Valle, F" uniqKey="Valle F">F Valle</name>
</author>
<author><name sortKey="Samori, B" uniqKey="Samori B">B Samorì</name>
</author>
<author><name sortKey="Bergantino, E" uniqKey="Bergantino E">E Bergantino</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Liu, D" uniqKey="Liu D">D Liu</name>
</author>
<author><name sortKey="Jin, L" uniqKey="Jin L">L Jin</name>
</author>
<author><name sortKey="Wang, H" uniqKey="Wang H">H Wang</name>
</author>
<author><name sortKey="Zhao, H" uniqKey="Zhao H">H Zhao</name>
</author>
<author><name sortKey="Zhao, C" uniqKey="Zhao C">C Zhao</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bellei, B" uniqKey="Bellei B">B Bellei</name>
</author>
<author><name sortKey="Maresca, V" uniqKey="Maresca V">V Maresca</name>
</author>
<author><name sortKey="Flori, E" uniqKey="Flori E">E Flori</name>
</author>
<author><name sortKey="Pitisci, A" uniqKey="Pitisci A">A Pitisci</name>
</author>
<author><name sortKey="Larue, L" uniqKey="Larue L">L Larue</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Duffy, Dl" uniqKey="Duffy D">DL Duffy</name>
</author>
<author><name sortKey="Zhao, Zz" uniqKey="Zhao Z">ZZ Zhao</name>
</author>
<author><name sortKey="Sturm, Ra" uniqKey="Sturm R">RA Sturm</name>
</author>
<author><name sortKey="Hayward, Nk" uniqKey="Hayward N">NK Hayward</name>
</author>
<author><name sortKey="Martin, Ng" uniqKey="Martin N">NG Martin</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wu, Y" uniqKey="Wu Y">Y Wu</name>
</author>
<author><name sortKey="Li, X" uniqKey="Li X">X Li</name>
</author>
<author><name sortKey="Xie, W" uniqKey="Xie W">W Xie</name>
</author>
<author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name>
</author>
<author><name sortKey="Le, W" uniqKey="Le W">W Le</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Pan, T" uniqKey="Pan T">T Pan</name>
</author>
<author><name sortKey="Rawal, P" uniqKey="Rawal P">P Rawal</name>
</author>
<author><name sortKey="Wu, Y" uniqKey="Wu Y">Y Wu</name>
</author>
<author><name sortKey="Xie, W" uniqKey="Xie W">W Xie</name>
</author>
<author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sarkar, S" uniqKey="Sarkar S">S Sarkar</name>
</author>
<author><name sortKey="Davies, Je" uniqKey="Davies J">JE Davies</name>
</author>
<author><name sortKey="Huang, Z" uniqKey="Huang Z">Z Huang</name>
</author>
<author><name sortKey="Tunnacliffe, A" uniqKey="Tunnacliffe A">A Tunnacliffe</name>
</author>
<author><name sortKey="Rubinsztein, Dc" uniqKey="Rubinsztein D">DC Rubinsztein</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sarkar, S" uniqKey="Sarkar S">S Sarkar</name>
</author>
<author><name sortKey="Ravikumar, B" uniqKey="Ravikumar B">B Ravikumar</name>
</author>
<author><name sortKey="Rubinsztein, Dc" uniqKey="Rubinsztein D">DC Rubinsztein</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Pan, T" uniqKey="Pan T">T Pan</name>
</author>
<author><name sortKey="Zhu, W" uniqKey="Zhu W">W Zhu</name>
</author>
<author><name sortKey="Zhao, H" uniqKey="Zhao H">H Zhao</name>
</author>
<author><name sortKey="Deng, H" uniqKey="Deng H">H Deng</name>
</author>
<author><name sortKey="Xie, W" uniqKey="Xie W">W Xie</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jiang, Ct" uniqKey="Jiang C">CT Jiang</name>
</author>
<author><name sortKey="Chang, Jy" uniqKey="Chang J">JY Chang</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wu, Y" uniqKey="Wu Y">Y Wu</name>
</author>
<author><name sortKey="Li, X" uniqKey="Li X">X Li</name>
</author>
<author><name sortKey="Zhu, J" uniqKey="Zhu J">J Zhu</name>
</author>
<author><name sortKey="Xie, W" uniqKey="Xie W">W Xie</name>
</author>
<author><name sortKey="Le, W" uniqKey="Le W">W Le</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Izykowska, I" uniqKey="Izykowska I">I Izykowska</name>
</author>
<author><name sortKey="Gebarowska, E" uniqKey="Gebarowska E">E Gebarowska</name>
</author>
<author><name sortKey="Cegielski, M" uniqKey="Cegielski M">M Cegielski</name>
</author>
<author><name sortKey="Podhorska Okolow, M" uniqKey="Podhorska Okolow M">M Podhorska-Okolow</name>
</author>
<author><name sortKey="Piotrowska, A" uniqKey="Piotrowska A">A Piotrowska</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gebhardt, C" uniqKey="Gebhardt C">C Gebhardt</name>
</author>
<author><name sortKey="Averbeck, M" uniqKey="Averbeck M">M Averbeck</name>
</author>
<author><name sortKey="Viertel, A" uniqKey="Viertel A">A Viertel</name>
</author>
<author><name sortKey="Kauer, F" uniqKey="Kauer F">F Kauer</name>
</author>
<author><name sortKey="Saalbach, A" uniqKey="Saalbach A">A Saalbach</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Pan, T" uniqKey="Pan T">T Pan</name>
</author>
<author><name sortKey="Kondo, S" uniqKey="Kondo S">S Kondo</name>
</author>
<author><name sortKey="Zhu, W" uniqKey="Zhu W">W Zhu</name>
</author>
<author><name sortKey="Xie, W" uniqKey="Xie W">W Xie</name>
</author>
<author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Baldea, I" uniqKey="Baldea I">I Baldea</name>
</author>
<author><name sortKey="Mocanl, T" uniqKey="Mocanl T">T Mocanl</name>
</author>
<author><name sortKey="Cosgarea, R" uniqKey="Cosgarea R">R Cosgarea</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bellei, B" uniqKey="Bellei B">B Bellei</name>
</author>
<author><name sortKey="Flori, E" uniqKey="Flori E">E Flori</name>
</author>
<author><name sortKey="Izzo, E" uniqKey="Izzo E">E Izzo</name>
</author>
<author><name sortKey="Maresca, V" uniqKey="Maresca V">V Maresca</name>
</author>
<author><name sortKey="Picardo, M" uniqKey="Picardo M">M Picardo</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Aoki, Y" uniqKey="Aoki Y">Y Aoki</name>
</author>
<author><name sortKey="Tanigawa, T" uniqKey="Tanigawa T">T Tanigawa</name>
</author>
<author><name sortKey="Abe, H" uniqKey="Abe H">H Abe</name>
</author>
<author><name sortKey="Fujiwara, Y" uniqKey="Fujiwara Y">Y Fujiwara</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Le, W" uniqKey="Le W">W Le</name>
</author>
<author><name sortKey="Pan, T" uniqKey="Pan T">T Pan</name>
</author>
<author><name sortKey="Huang, M" uniqKey="Huang M">M Huang</name>
</author>
<author><name sortKey="Xu, P" uniqKey="Xu P">P Xu</name>
</author>
<author><name sortKey="Xie, W" uniqKey="Xie W">W Xie</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lindsey, Jd" uniqKey="Lindsey J">JD Lindsey</name>
</author>
<author><name sortKey="Jones, Hl" uniqKey="Jones H">HL Jones</name>
</author>
<author><name sortKey="Hewitt, Eg" uniqKey="Hewitt E">EG Hewitt</name>
</author>
<author><name sortKey="Angert, M" uniqKey="Angert M">M Angert</name>
</author>
<author><name sortKey="Weinreb, Rn" uniqKey="Weinreb R">RN Weinreb</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Halaban, R" uniqKey="Halaban R">R Halaban</name>
</author>
<author><name sortKey="Cheng, E" uniqKey="Cheng E">E Cheng</name>
</author>
<author><name sortKey="Zhang, Y" uniqKey="Zhang Y">Y Zhang</name>
</author>
<author><name sortKey="Moellmann, G" uniqKey="Moellmann G">G Moellmann</name>
</author>
<author><name sortKey="Hanlon, D" uniqKey="Hanlon D">D Hanlon</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Iozumi, K" uniqKey="Iozumi K">K Iozumi</name>
</author>
<author><name sortKey="Hoganson, Ge" uniqKey="Hoganson G">GE Hoganson</name>
</author>
<author><name sortKey="Pennella, R" uniqKey="Pennella R">R Pennella</name>
</author>
<author><name sortKey="Everett, Ma" uniqKey="Everett M">MA Everett</name>
</author>
<author><name sortKey="Fuller, Bb" uniqKey="Fuller B">BB Fuller</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Miller, Aj" uniqKey="Miller A">AJ Miller</name>
</author>
<author><name sortKey="Tsao, H" uniqKey="Tsao H">H Tsao</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Park, Hy" uniqKey="Park H">HY Park</name>
</author>
<author><name sortKey="Kosmadaki, M" uniqKey="Kosmadaki M">M Kosmadaki</name>
</author>
<author><name sortKey="Yaar, M" uniqKey="Yaar M">M Yaar</name>
</author>
<author><name sortKey="Gilchrest, Ba" uniqKey="Gilchrest B">BA Gilchrest</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cui, R" uniqKey="Cui R">R Cui</name>
</author>
<author><name sortKey="Widlund, Hr" uniqKey="Widlund H">HR Widlund</name>
</author>
<author><name sortKey="Feige, E" uniqKey="Feige E">E Feige</name>
</author>
<author><name sortKey="Lin, Jy" uniqKey="Lin J">JY Lin</name>
</author>
<author><name sortKey="Wilensky, Dl" uniqKey="Wilensky D">DL Wilensky</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Verkrellis, K" uniqKey="Verkrellis K">K Verkrellis</name>
</author>
<author><name sortKey="Xilouri, M" uniqKey="Xilouri M">M Xilouri</name>
</author>
<author><name sortKey="Emmanouilidou, E" uniqKey="Emmanouilidou E">E Emmanouilidou</name>
</author>
<author><name sortKey="Rideout, H" uniqKey="Rideout H">H Rideout</name>
</author>
<author><name sortKey="Stefanis, L" uniqKey="Stefanis L">L Stefanis</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sulzer, D" uniqKey="Sulzer D">D Sulzer</name>
</author>
<author><name sortKey="Bogulavsky, J" uniqKey="Bogulavsky J">J Bogulavsky</name>
</author>
<author><name sortKey="Larsen, Ke" uniqKey="Larsen K">KE Larsen</name>
</author>
<author><name sortKey="Behr, G" uniqKey="Behr G">G Behr</name>
</author>
<author><name sortKey="Karatekin, E" uniqKey="Karatekin E">E Karatekin</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Xuan, Q" uniqKey="Xuan Q">Q Xuan</name>
</author>
<author><name sortKey="Xu, Sl" uniqKey="Xu S">SL Xu</name>
</author>
<author><name sortKey="Lu, Dh" uniqKey="Lu D">DH Lu</name>
</author>
<author><name sortKey="Yu, S" uniqKey="Yu S">S Yu</name>
</author>
<author><name sortKey="Zhou, M" uniqKey="Zhou M">M Zhou</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Dusek, P" uniqKey="Dusek P">P Dusek</name>
</author>
<author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name>
</author>
<author><name sortKey="Le, W" uniqKey="Le W">W Le</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="De Marco, F" uniqKey="De Marco F">F De Marco</name>
</author>
<author><name sortKey="Foppoli, C" uniqKey="Foppoli C">C Foppoli</name>
</author>
<author><name sortKey="Coccia, R" uniqKey="Coccia R">R Coccia</name>
</author>
<author><name sortKey="Blarzino, C" uniqKey="Blarzino C">C Blarzino</name>
</author>
<author><name sortKey="Perluigi, M" uniqKey="Perluigi M">M Perluigi</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Zecca, L" uniqKey="Zecca L">L Zecca</name>
</author>
<author><name sortKey="Tampellini, D" uniqKey="Tampellini D">D Tampellini</name>
</author>
<author><name sortKey="Gatti, A" uniqKey="Gatti A">A Gatti</name>
</author>
<author><name sortKey="Crippa, R" uniqKey="Crippa R">R Crippa</name>
</author>
<author><name sortKey="Eisner, M" uniqKey="Eisner M">M Eisner</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Enochs, Ws" uniqKey="Enochs W">WS Enochs</name>
</author>
<author><name sortKey="Sarna, T" uniqKey="Sarna T">T Sarna</name>
</author>
<author><name sortKey="Zecca, L" uniqKey="Zecca L">L Zecca</name>
</author>
<author><name sortKey="Riley, Pa" uniqKey="Riley P">PA Riley</name>
</author>
<author><name sortKey="Swartz, Hm" uniqKey="Swartz H">HM Swartz</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Stepie, K" uniqKey="Stepie K">K Stepień</name>
</author>
<author><name sortKey="Dzierzega Lecznar, A" uniqKey="Dzierzega Lecznar A">A Dzierzega-Lecznar</name>
</author>
<author><name sortKey="Tam, I" uniqKey="Tam I">I Tam</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Fasano, M" uniqKey="Fasano M">M Fasano</name>
</author>
<author><name sortKey="Bergamasco, B" uniqKey="Bergamasco B">B Bergamasco</name>
</author>
<author><name sortKey="Lopiano, L" uniqKey="Lopiano L">L Lopiano</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Zecca, L" uniqKey="Zecca L">L Zecca</name>
</author>
<author><name sortKey="Zucca, Fa" uniqKey="Zucca F">FA Zucca</name>
</author>
<author><name sortKey="Albertini, A" uniqKey="Albertini A">A Albertini</name>
</author>
<author><name sortKey="Rizzio, E" uniqKey="Rizzio E">E Rizzio</name>
</author>
<author><name sortKey="Fariello, Rg" uniqKey="Fariello R">RG Fariello</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nicolaus, Bj" uniqKey="Nicolaus B">BJ Nicolaus</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Li, J" uniqKey="Li J">J Li</name>
</author>
<author><name sortKey="Yang, J" uniqKey="Yang J">J Yang</name>
</author>
<author><name sortKey="Zhao, P" uniqKey="Zhao P">P Zhao</name>
</author>
<author><name sortKey="Li, S" uniqKey="Li S">S Li</name>
</author>
<author><name sortKey="Zhang, R" uniqKey="Zhang R">R Zhang</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Xu, J" uniqKey="Xu J">J Xu</name>
</author>
<author><name sortKey="Kao, Sy" uniqKey="Kao S">SY Kao</name>
</author>
<author><name sortKey="Lee, Fj" uniqKey="Lee F">FJ Lee</name>
</author>
<author><name sortKey="Song, W" uniqKey="Song W">W Song</name>
</author>
<author><name sortKey="Jin, Lw" uniqKey="Jin L">LW Jin</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ando, H" uniqKey="Ando H">H Ando</name>
</author>
<author><name sortKey="Funasaka, Y" uniqKey="Funasaka Y">Y Funasaka</name>
</author>
<author><name sortKey="Oka, M" uniqKey="Oka M">M Oka</name>
</author>
<author><name sortKey="Ohashi, A" uniqKey="Ohashi A">A Ohashi</name>
</author>
<author><name sortKey="Furumura, M" uniqKey="Furumura M">M Furumura</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group><journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher><publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">23028833</article-id>
<article-id pub-id-type="pmc">3446957</article-id>
<article-id pub-id-type="publisher-id">PONE-D-12-15910</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0045183</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2"><subject>Biology</subject>
<subj-group><subject>Molecular Cell Biology</subject>
<subj-group><subject>Cellular Types</subject>
<subj-group><subject>Neurons</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject>
<subj-group><subject>Dermatology</subject>
<subj-group><subject>Skin Neoplasms</subject>
<subj-group><subject>Malignant Skin Neoplasms</subject>
<subj-group><subject>Melanomas</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group><subject>Epidemiology</subject>
<subj-group><subject>Clinical Epidemiology</subject>
</subj-group>
</subj-group>
<subj-group><subject>Neurology</subject>
<subj-group><subject>Parkinson Disease</subject>
</subj-group>
</subj-group>
<subj-group><subject>Oncology</subject>
<subj-group><subject>Cancer Risk Factors</subject>
<subj-group><subject>Aging and Cancer</subject>
<subject>Environmental Causes of Cancer</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group><subject>Public Health</subject>
<subj-group><subject>Disease Ecology</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v2"><subject>Physics</subject>
<subj-group><subject>Electromagnetic Radiation</subject>
<subj-group><subject>Ultraviolet Radiation</subject>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group><article-title>The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells</article-title>
<alt-title alt-title-type="running-head">Alpha-Synuclein in Melanin Synthesis</alt-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Pan</surname>
<given-names>Tianhong</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1"><sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Zhu</surname>
<given-names>Julie</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Hwu</surname>
<given-names>Wen-Jen</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Jankovic</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>
<addr-line>Neurology Department, Parkinson Disease Research Laboratory, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</aff>
<aff id="aff2"><label>2</label>
<addr-line>Melanoma Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
</aff>
<aff id="aff3"><label>3</label>
<addr-line>Parkinson’s Disease Center and Movement Disorder Clinic, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>
</aff>
<contrib-group><contrib contrib-type="editor"><name><surname>Paudel</surname>
<given-names>Hemant K.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>McGill University Department of Neurology and Neurosurgery, Canada</addr-line>
</aff>
<author-notes><corresp id="cor1">* E-mail: <email>tpan@bcm.edu</email>
</corresp>
<fn fn-type="conflict"><p><bold>Competing Interests: </bold>
The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con"><p>Conceived and designed the experiments: TP JJ WJH. Performed the experiments: JZ TP. Analyzed the data: TP. Contributed reagents/materials/analysis tools: JZ TP. Wrote the paper: TP JJ WJH.</p>
</fn>
</author-notes>
<pub-date pub-type="collection"><year>2012</year>
</pub-date>
<pub-date pub-type="epub"><day>19</day>
<month>9</month>
<year>2012</year>
</pub-date>
<volume>7</volume>
<issue>9</issue>
<elocation-id>e45183</elocation-id>
<history><date date-type="received"><day>1</day>
<month>6</month>
<year>2012</year>
</date>
<date date-type="accepted"><day>17</day>
<month>8</month>
<year>2012</year>
</date>
</history>
<permissions><copyright-year>2012</copyright-year>
<copyright-holder>Pan et al</copyright-holder>
<license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<abstract><p>The relatively high co-occurrence of Parkinson’s disease (PD) and melanoma has been established by a large number of epidemiological studies. However, a clear biological explanation for this finding is still lacking. Ultra-violet radiation (UVR)-induced skin melanin synthesis is a defense mechanism against UVR-induced damage relevant to the initiation of melanoma, whereas, increased neuromelanin (NM), the melanin synthesized in dopaminergic neurons, may enhance the susceptibility to oxidative stress-induced neuronal injury relevant to PD. <italic>SNCA</italic>
is a PD-causing gene coding for alpha-Synuclein (α-Syn) that expresses not only in brain, but also in skin as well as in tumors, such as melanoma. The findings that α-Syn can interact with tyrosinase (TYR) and inhibit tyrosine hydroxylase (TH), both of which are enzymes involved in the biosynthesis of melanin and dopamine (DA), led us to propose that α-Syn may participate in the regulation of melanin synthesis. In this study, by applying ultraviolet B (UVB) light, a physiologically relevant stimulus of melanogenesis, we detected melanin synthesis in A375 and SK-MEL-28 melanoma cells and in SH-SY5Y and PC12 dopaminergic neuronal cells and determined effects of α-Syn on melanin synthesis. Our results showed that UVB light exposure increased melanin synthesis in all 4 cell lines. However, we found that α-Syn expression reduced UVB light-induced increase of melanin synthesis and that melanin content was lower when melanoma cells were expressed with α-Syn, indicating that α-Syn may have inhibitory effects on melanin synthesis in melanoma cells. Different from melanoma cells, the melanin content was higher in α-Syn-over-expressed dopaminergic neuronal SH-SY5Y and PC12 cells, cellular models of PD, than that in non-α-Syn-expressed control cells. We concluded that α-Syn could be one of the points responsible for the positive association between PD and melanoma via its differential roles in melanin synthesis in melanoma cells and in dopaminergic neuronal cells.</p>
</abstract>
<funding-group><funding-statement>This work was supported by Michael J. Fox Foundation for Parkinson’s Research-Rapid Response Innovation Awards 2011 (RRIA 2011) (to T.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts><page-count count="8"></page-count>
</counts>
</article-meta>
</front>
<body><sec id="s1"><title>Introduction</title>
<p>Melanoma is the most dangerous form of skin cancers, characterized by uncontrolled growth of skin melanocytes, whereas, Parkinson’s disease (PD) is one of the neurodegenerative disorders, characterized by a progressive loss of pigmented dopamine (DA) neurons in the substantia nigra (SN). Although PD and melanoma are two different diseases, numerous epidemiological studies have established an increased incidence of melanoma in patients with PD and vice verse <xref ref-type="bibr" rid="pone.0045183-Liu1">[1]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Driver1">[5]</xref>
. However, the pathogenic pathways responsible for this link have not yet been fully defined <xref ref-type="bibr" rid="pone.0045183-Pan1">[6]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Inzelberg2">[10]</xref>
.</p>
<p>Exposure of skin to sunlight or to tanning machines and in particular exposure to ultra-violet radiation (UVR) may lead to DNA damage-initiated development of melanoma <xref ref-type="bibr" rid="pone.0045183-Izykowska1">[11]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Jiang1">[13]</xref>
, which process can be prevented by skin melanin. Thus, skin melanin synthesis is considered as a defense mechanism against UVR-induced initiation of melanoma <xref ref-type="bibr" rid="pone.0045183-Harbour1">[14]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Dwyer1">[15]</xref>
. Melanin is a determinant of skin color. Light skin color such as that in Caucasian populations contains less melanin. The findings that the incidence of both melanoma <xref ref-type="bibr" rid="pone.0045183-Harbour1">[14]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Aitken1">[16]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Weinstock1">[17]</xref>
and PD <xref ref-type="bibr" rid="pone.0045183-WrightWillis1">[18]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Elbaz1">[20]</xref>
is higher in Caucasian populations than that in black populations indicate that in addition to melanoma, low skin melanin level may also enhance the vulnerability to PD.</p>
<p>Although the etiology of dopaminergic neuronal degeneration in PD remains unknown, alpha-Synuclein (α-Syn) gene (<italic>SNCA</italic>
) has been implicated in the pathogenesis of both familial and sporadic PD <xref ref-type="bibr" rid="pone.0045183-Shulman1">[21]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Polymeropoulos1">[23]</xref>
. α-Syn, predominantly expressed in the brain, has been found to accumulate in the peripheral nervous system <xref ref-type="bibr" rid="pone.0045183-Shishido1">[24]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Ikemura1">[26]</xref>
and to be directly transmitted from pathologically affected neurons to healthy, unaffected cells <xref ref-type="bibr" rid="pone.0045183-Luk1">[27]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Olanow1">[28]</xref>
. α-Syn is also reported to be expressed in skin <xref ref-type="bibr" rid="pone.0045183-Ikemura1">[26]</xref>
as well as in various tumors including ovarian and breast <xref ref-type="bibr" rid="pone.0045183-Bruening1">[29]</xref>
, colorectal <xref ref-type="bibr" rid="pone.0045183-Ye1">[30]</xref>
and melanoma <xref ref-type="bibr" rid="pone.0045183-Matsuo1">[31]</xref>
. Tyrosinase (TYR) and tyrosine hydroxylase (TH) are enzymes involved in the biosynthesis of melanin and dopamine (DA) initiated by the conversion of tyrosine to DOPA <xref ref-type="bibr" rid="pone.0045183-Peng1">[32]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Ando1">[34]</xref>
. The findings that α-Syn can interact with TYR <xref ref-type="bibr" rid="pone.0045183-Tessari1">[35]</xref>
and inhibit TH <xref ref-type="bibr" rid="pone.0045183-Peng1">[32]</xref>
, raise the possibility that α-Syn may play a role in regulating the biosynthesis of melanin and DA.</p>
<p>Ultra-violet B (UVB) light is physiologically relevant to UVR that may stimulate melanogenesis by enhancing melanin synthesis via an enzymatic cascade controlled by certain pigmentation genes <xref ref-type="bibr" rid="pone.0045183-Bellei1">[37]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Duffy1">[38]</xref>
. In this study, we applied UVB light on SK-MEL-28 and A375 human melanoma cells to determine roles of α-Syn in melanin synthesis. We also used α-Syn over-expressed SH-SY5Y cells and PC12 as PD cellular models to determine roles of α-Syn in melanin synthesis in dopaminergic neuronal cells. We found that α-Syn plays differential roles in melanin synthesis in melanoma and dopaminergic neuronal cells, which may explain the increased incidence of melanoma in PD patients.</p>
</sec>
<sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title>
<sec id="s2a"><title>Cell Cultures and Transfection</title>
<p>A375 melanoma cells (ATCC, Manassas, VA) and SH-SY5Y cells <xref ref-type="bibr" rid="pone.0045183-Wu1">[39]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Pan2">[40]</xref>
were routinely grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (GIBCO, Gaithersburg, MD). SK-MEL-28 melanoma cells (ATCC, Manassas, VA) known to have high expression of α-Syn <xref ref-type="bibr" rid="pone.0045183-Matsuo1">[31]</xref>
were maintained in Eagle’s Minimum Essential medium (EMEM) (ATCC, Manassas, VA) supplemented with 10% FBS. Stable inducible PC12 cells expressing HA-tagged wild-type α-Syn (kind gift of professor David Rubinsztein from Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge) <xref ref-type="bibr" rid="pone.0045183-Sarkar1">[41]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Sarkar2">[42]</xref>
were maintained at 70 µg/ml hygromycin B (Calbiochem), 50 µg/ml G418 (Sigma), 10% horse serum and 5% FBS DMEM. All cells were cultured at 37°C under humidified 5% CO<sub>2</sub>
atmosphere.</p>
<p>To silence endogenous α-Syn expression, SK-MEL-28 melanoma cells were transfected with small interference RNA (siRNA) of <italic>SNCA</italic>
(siRNA ID S13206, Ambion INC, Austin, TX, USA) at concentration of 100 nM using lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA) as we described previously <xref ref-type="bibr" rid="pone.0045183-Pan3">[43]</xref>
. Silencer™ negative control #3 siRNA (Ambio INC), with no significant homology to any known gene sequences from mouse, rat and human, was used as a sham control. To establish cells with wild type (wt)-α-Syn over-expression, A375 melanoma cells and SH-SY5Y cells were transfected with wt-α-Syn expression plasmid (Kind gift from Dr. Chuantao Jiang, Research Center for Protein Chemistry, Department of Biochemistry and Molecular Biology, The University of Texas, Houston, Texas) <xref ref-type="bibr" rid="pone.0045183-Jiang2">[44]</xref>
using lipofectamine™ 2000. Cells transfected with pGEX-1 control vector were used as control. In order to maintain consistent levels of insert α-Syn expression between experiments, 48 h after transfection, A375 and SH-SY5Y cells were exposed to medium containing G418 (800 µg/ml) for 2 weeks. The selected polyclonal pools of stable transfected cells were passed and maintained in culture medium containing G418 (200 µg/ml) for experimental assays. The expression of wt-α-Syn in stable inducible PC12 cells was induced by 1 µg/ml doxycycline (Sigma) for 48 h as we described previously <xref ref-type="bibr" rid="pone.0045183-Wu2">[45]</xref>
.</p>
</sec>
<sec id="s2b"><title>UVB Light Irradiation</title>
<p>Irradiation was conducted using a 6W-power UVB lamp (Cole-Parmer, Vernon Hills, IL, USA) with a wavelength spectrum of 280–320 nm. Sub-confluent cells were washed and irradiated in phosphate buffered saline (PBS) with energy of UVB emission amounted to 2.2 mW/cm<sup>2</sup>
at a target distance of 3 inches. The exposure of cells to UVB light for 13, 54, and 110 seconds corresponds to doses of 30, 120, and 240 mJ/cm<sup>2</sup>
UVB respectively. Immediately after irradiation, the cells were changed with fresh cell culture medium and returned to the incubator and cultivated for the indicated time periods <xref ref-type="bibr" rid="pone.0045183-Izykowska2">[46]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Gebhardt1">[47]</xref>
.</p>
</sec>
<sec id="s2c"><title>Cell Viability</title>
<p>The general viability of cultured cells were determined by reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide; Sigma, St. Louis, MI) to formazan as we reported previously <xref ref-type="bibr" rid="pone.0045183-Pan4">[48]</xref>
. The cytotoxicity-based MTT assay was performed with three UVB radiation doses: 30, 120 and 240 mJ/cm<sup>2</sup>
and post-cultured for 4, 24 and 48 h.</p>
</sec>
<sec id="s2d"><title>Total Melanin Content</title>
<p>The melanin content was determined according to previous publications with modifications <xref ref-type="bibr" rid="pone.0045183-Bellei1">[37]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Baldea1">[49]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Aoki1">[51]</xref>
. Briefly, the content of extracellular melanin was measured directly from cell culture medium spectrophotometrically at 415 nm using iMark Microplate Reader. For the cellular melanin, the adherent cells were washed with PBS and detached by trypsinization, resuspended in culture medium. Fifty microliters of cell suspension were used for counting cell numbers with hemacytometer under microscope. Other cell suspensions were centrifuged and re-suspended in 1 M NaOH and incubated at 80°C for 30 minutes followed by centrifugation at 1,500 rpm for 5 minutes. The absorbance of the supernatant was measured at 415 nm. The amount of melanin was compared with the standard curve of the serial dilution of standard melanin (Sigma, USA) and was normalized to the total number of cells and expressed as microgram per 1×10<sup>4</sup>
cells (µg/10<sup>4</sup>
cells). The total amount of melanin was come from the sum of extracellular (medium) and intracellular melanin.</p>
</sec>
<sec id="s2e"><title>Tyrosinase (TYR) Enzyme Activity</title>
<p>TYR enzyme activity was estimated by measuring the rate of L-DOPA (3,4-dihydroxyphenylalanine) oxidation as previously described <xref ref-type="bibr" rid="pone.0045183-Bellei1">[37]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Bellei2">[50]</xref>
with slight modifications. Briefly, after specific treatment, the adherent cells were washed three times with PBS and then lysed in PBS containing 1% Triton X-100. After protein quantification, equal amount of protein were aliquoted into the wells of a 96-well plate. Then, 20 µl of 5 mM L-DOPA was added to each plate well, incubated at 37°C and allowed to react for 45 min. The end-point absorbance was measured spectrophotometrically at 475 nm using iMark Microplate Reader. The results were expressed as percentage of non-UVB control.</p>
</sec>
<sec id="s2f"><title>Release of Dopamine (DA) as Determined by Extra-cellular DA Content</title>
<p>The release of DA was determined by measuring DA content in cell culture medium using high-pressure liquid chromatography (HPLC) according to the method we described previously <xref ref-type="bibr" rid="pone.0045183-Pan4">[48]</xref>
. Briefly, cell culture medium 100 µl was lysed with 50 µl of 0.1 M perchloride acid. Homogenates were centrifuged at 13,000 rpm for 10 min at 4°C. The resulted supernatants were filtered by acro-disc filters (mesh size, 0.25 µm Fisher, Scientific, Houston, TX) before being subjected to HPLC assay. The DA content was normalized to the total amount of protein and expressed as nanogramme (ng) per milligram (mg) protein (ng/mg protein) and results were expressed as percentage of non-UVB control.</p>
</sec>
<sec id="s2g"><title>Protein Isolation and Western Blot Analysis</title>
<p>Total proteins were isolated with mammalian tissue lysis/extraction reagent supplemented with protease inhibitor cocktails (Sigma, St. Louis, MO). The equal amounts of protein were subjected to western blot assay as we described previously <xref ref-type="bibr" rid="pone.0045183-Wu1">[39]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Wu2">[45]</xref>
. The protein levels of α-Syn and TYR were determined using anti-α-Syn [4D6] antibody (Abcam) and anti-TYR antibody (Santa Cruz Biotechnology, Santa Cruz, CA). Immunoblot of <italic>β</italic>
-actin (Santa Cruz Biotechnology, Inc) was performed to demonstrate equal protein loading.</p>
</sec>
<sec id="s2h"><title>RNA Isolation and Real-time Quantitative PCR</title>
<p>Total RNA was extracted from cells with Direc-zol™ RNA Miniprep kit (The Epigenetics Company). The iScript one-step RT-PCR kit with SYBR Green (Bio-rad) was used for real-time quantitative PCR of RNA templates, in which, cDNA synthesis and PCR amplification were carried out in the same tube. Specific primers for human TYR were based on published nucleotide sequences (forward: <named-content content-type="gene">5′-GGCTGTTTTGTACTGCCTGCT-3′</named-content>
; reverse: 5′ AGGAGACACAGGCTCTAGGGAA-3′) <xref ref-type="bibr" rid="pone.0045183-Lindsey1">[53]</xref>
. Human <italic>ß</italic>
-actin gene was used as internal control. Specific primers for <italic>ß</italic>
-actin were designed using primer 3 and BLAST system (NCBI) (forward: <named-content content-type="gene">5′-GGGACCTGACTGACTACCTCA-3′</named-content>
; reverse: <named-content content-type="gene">5′-CAGCTTCTCCTTAATGTCACG-3′</named-content>
). Real-time quantitative PCR was performed in a 25 µl solution containing 100 ng of RNA templet, 0.3 µM of primers, and SYBR Green 12.5 µl. The value of threshold cycle (Ct) was generated at every cycle during a run. Fluorescent reading from real-time PCR reaction was quantitatively analyzed by determining the difference of Ct (delta Ct) between Ct of <italic>TYR</italic>
gene and Ct of <italic>ß-actin</italic>
gene. The gene expression of TYR was determined by the formation of 2<sup>−delta Ct</sup>
as we reported previously <xref ref-type="bibr" rid="pone.0045183-Pan3">[43]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Le1">[52]</xref>
. The relative gene expression was expressed as percentage of non-UVB control.</p>
</sec>
<sec id="s2i"><title>Statistical Analysis</title>
<p>All data were collected from three or more independent experiments and values were expressed as means ± SD. Statistical analysis was performed by one-way analysis of variance (ANOVA) using original software (Microcal Inc., Northampton, Mass., USA). p values lower than 0.05 were considered statistically significant difference.</p>
</sec>
</sec>
<sec id="s3"><title>Results</title>
<sec id="s3a"><title>Doses of UVB Light as Determined by MTT Assay</title>
<p>MTT assay showed that UVB light exposure caused loss of cell viability in both A375 and SK-MEL-28 melanoma cells time- and dose-dependently (<xref ref-type="fig" rid="pone-0045183-g001">Fig. 1A, 1B, 1C</xref>
). At the dose of 120 mJ/cm<sup>2</sup>
, the cell viability was significantly decreased by 42% in A375 and by 20% in SK-MEL-28 melanoma cells 48 h after UVB light exposure (<xref ref-type="fig" rid="pone-0045183-g001">Fig. 1B</xref>
), whereas, the changes were not significant 4 and 24 h after UVB light exposure. Hence, a dose of UVB at 120 mJ/cm<sup>2</sup>
and post-culture for 24 h were chosen for further experiments.</p>
<fig id="pone-0045183-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0045183.g001</object-id>
<label>Figure 1</label>
<caption><title>UVB light-induced loss of cell viability.</title>
<p>A375 and SK-MEL-28 melanoma cells were exposed to UVB light at the doses of 30 mJ/cm<sup>2</sup>
(A), 120 mJ/cm<sup>2</sup>
(B) and 240 mJ/cm<sup>2</sup>
(C) and post-cultured for 4 h, 24 h and 48 h (A, B, C). Cell viability was determined by MTT assay. The results were expressed as percentage of non-UVB control. *: p<0.05; **: p<0.01 as compared to its non-UVB control (0 h).</p>
</caption>
<graphic xlink:href="pone.0045183.g001"></graphic>
</fig>
</sec>
<sec id="s3b"><title>Differential Roles of α-Syn in Melanin Synthesis</title>
<p>Western blot assay showed that transfection of cells with wt-α-Syn expression plasmid increased α-Syn protein level in both A375 melanoma cells (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2A</xref>
, upper panel) and in SH-SY5Y dopaminergic neuronal cells (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2C</xref>
, upper panel). It also showed that the protein level of α-Syn was higher in the inducible PC12 cells treated with doxycycline than that in non-doxycycline-treated PC12 cells (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2D</xref>
, upper panel). Moreover, the endogenous expression of α-Syn was decreased in SK-MEL-28 melanoma cells transfected with <italic>SNCA</italic>
siRNA for 72 h (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2B</xref>
, upper panel), indicating the suppression of α-Syn.</p>
<fig id="pone-0045183-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0045183.g002</object-id>
<label>Figure 2</label>
<caption><title>Roles of α-Syn in melanin synthesis in melanoma and dopaminergic neuronal cells.</title>
<p>A375 melanoma cells (A) and dopaminergic neuronal SH-SY5Y and PC12 cells (C, D) with or without wt-α-Syn over-expression, SK-MEL-28 melanoma cells (B) with or without suppression of endogenous α-Syn, were exposed to UVB light (120 mJ/cm<sup>2</sup>
) or non-UVB light and post-cultured for 24 h. The protein levels of α-Syn were determined by western blot assay (A, B, C, D, upper panel). Melanin content was determined spectrophotometrically at 415 nm using iMark Microplate Reader (A, B, C, D, lower panel). *: p<0.05; **: p<0.01; *** p<0.001 as compared to its non-UVB control (a), non-α-Syn control (b), or vector/<italic>#3</italic>
siRNA control (c). Dox = doxycycline.</p>
</caption>
<graphic xlink:href="pone.0045183.g002"></graphic>
</fig>
<p>In the parallel experiments, we found that UVB light irradiation increased melanin synthesis by 184%, 155% and by 179% in non-α-Syn-overexpressed A375 melanoma cells, SH-SY5Y and PC12 neuronal cells respectively, whereas, it was increased by 160%, 148% and by 167% in wt-α-Syn-over-expressed A375 melanoma cells, SH-SY5Y and PC12 neuronal cells as compared to its non-UVB light-exposed control cells (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2A, 2C, 2D</xref>
, lower panel). Moreover, the melanin content was increased by 128% and by 117% respectively in SK-MEL-28 melanoma cells with or without suppression of endogenous α-Syn by <italic>SNCA</italic>
siRNA transfection (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2B</xref>
, lower panel).</p>
<p>Since UVB light-exposed neuronal cells do not represent cellular models of PD, we further analyzed roles of α-Syn in melanin content in PD cellular models, including α-Syn-expressed SH-SY5Y and PC12 dopaminergic neuronal cells. Different from melanoma cells, we found that, under the conditions of both non-UVB and UVB light exposure, the melanin content was 2.9 and 2.7 times higher in α-Syn-over-expressed SH-SY5Y cells than that in its non-α-Syn-expressed SH-SY5Y control cells (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2C</xref>
, lower panel) and it was 1.3 and 1.2 times higher in α-Syn-expressed PC12 cells (treated with doxycycline) than that in its non-α-Syn-induced control PC12 cells (<xref ref-type="fig" rid="pone-0045183-g002">Fig. 2D</xref>
, lower panel), indicating that α-Syn could be associated with an increase of melanin content in dopaminergic neuronal cells.</p>
</sec>
<sec id="s3c"><title>Inhibitory Effects α-Syn on Tyrosinase (TYR) Activity</title>
<p>TYR is one of the critical enzymes for the initiation of melanogenesis <xref ref-type="bibr" rid="pone.0045183-Halaban1">[54]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Iozumi1">[55]</xref>
. Our results showed that UVB light exposure was associated with an increase of TYR activity by 160%, 138% and by 117% in non-α-Syn over-expressed A375, SH-SY5Y and PC12 cells, whereas, it was increased by 127%, 111% and 109% in α-Syn over-expressed A375, SH-SY5Y and PC12 cells as compared to its non-UVB light-exposed control cells (<xref ref-type="fig" rid="pone-0045183-g003">Fig. 3A, 3C, 3D</xref>
). Our results also revealed that UVB light exposure caused an increase of TYR activity by 112% in α-Syn-suppressed SK-MEL-28 melanoma cells as compared to its non-UVB light-exposed control cells (<xref ref-type="fig" rid="pone-0045183-g003">Fig. 3B</xref>
). However, the change was not significant in SK-MEL28 melanoma cells transfected with <italic>#3</italic>
siRNA, in which, endogenous α-Syn was expressed (<xref ref-type="fig" rid="pone-0045183-g003">Fig. 3B</xref>
).</p>
<fig id="pone-0045183-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0045183.g003</object-id>
<label>Figure 3</label>
<caption><title>Effects of α-Syn on the activation of tyrosinase (TYR) induced by UVB light.</title>
<p>After cells were exposed to UVB light (120 mJ/cm<sup>2</sup>
) and post-cultured for 24 h, the TYR activity was measured spectrophotometrically at 475 nm using iMark Microplate Reader. Cells without UVB light exposure (non-UVB) were used as a control. A: A375 melanoma cells; B: SK-MEL-28 melanoma cells; C: SH-SY5Y dopaminergic neuronal cells; D: PC12 dopaminergic neuronal cells. *: p<0.05; **: p<0.01 as compared to its non-UVB control (a) or non-α-Syn control (b). Dox = doxycycline.</p>
</caption>
<graphic xlink:href="pone.0045183.g003"></graphic>
</fig>
</sec>
<sec id="s3d"><title>α-Syn Expression Decreases Extra-cellular DA Content</title>
<p>Both melanoma cells and dopaminergic neuronal cells share a common pathway in the initiation of biosynthesis of melanin and DA from tyrosine. In this study, we measured extra-cellular DA level from cell culture medium, which is an indicator of DA release. HPLC assay revealed that UVB light exposure caused decrease of extra-cellular DA level by 28%, 62% and 58% in non-α-Syn-expressed A375, SH-SY5Y and PC12 cells respectively, whereas, it was decreased by 14%, 12% and 24% in those cells over-expressed with α-Syn as compared to its non-UVB-exposed control cells (<xref ref-type="fig" rid="pone-0045183-g004">Fig. 4A, 4C, 4D</xref>
). After endogenous α-Syn-expressed SK-MEL-28 melanoma cells were exposed to UVB light and post-cultured for 24 h, there was no significant change in the content of extra-cellular DA (<xref ref-type="fig" rid="pone-0045183-g004">Fig. 4B</xref>
). However, when α-Syn was suppressed by <italic>SNCA</italic>
siRNA transfection, the extra-cellular DA level was decreased by 29% as compared to it non-UVB-exposed control cells (<xref ref-type="fig" rid="pone-0045183-g004">Fig. 4B</xref>
).</p>
<fig id="pone-0045183-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0045183.g004</object-id>
<label>Figure 4</label>
<caption><title>Extra-cellular dopamine (DA) content as determined by HPLC assay.</title>
<p>After cells were exposed to UVB light (120 mJ/cm<sup>2</sup>
) or non-UVB light and post-cultured for 24 h, cell culture medium from melanoma A375 cells (A) and SK-MEL-28 cells (B), dopaminergic neuronal SH-SY5Y cells (C) and PC12 cells (D) with or without α-Syn expression were subjected to HPLC assay for measuring DA level. *: p<0.05 as compared to its non-UVB control (a) or non-α-Syn control (b). Dox = doxycycline.</p>
</caption>
<graphic xlink:href="pone.0045183.g004"></graphic>
</fig>
</sec>
<sec id="s3e"><title>Role of α-Syn in the Expression of TYR</title>
<p>We further evaluated whether the changes in TYR activity were related to the changes of TYR expression. Real-time quantitative PCR revealed that UVB light exposure significantly increased TYR mRNA level by 270% in non-α-Syn-expressed A375 melanoma cells, whereas, there was no significant change in α-Syn-over-expressed A375 melanoma cells (<xref ref-type="fig" rid="pone-0045183-g005">Fig. 5A</xref>
). We also showed that UVB light exposure caused a significant increase of TYR gene expression by 357% in non-α-Syn-expressed SH-SY5Y cells and by 349% in α-Syn-expressed SH-SY5Y cells (<xref ref-type="fig" rid="pone-0045183-g005">Fig. 5B</xref>
). However, western blot assay did not show an increase of TYR protein level in either A375 melanoma cells (<xref ref-type="fig" rid="pone-0045183-g005">Fig. 5C</xref>
) or in SH-SY5Y dopaminergic neuronal cells (<xref ref-type="fig" rid="pone-0045183-g005">Fig. 5D</xref>
).</p>
<fig id="pone-0045183-g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0045183.g005</object-id>
<label>Figure 5</label>
<caption><title>UVB light-induced changes in gene expression and protein level of TYR.</title>
<p>A375 (A) and SH-SY5Y cells (B) with or without α-Syn expression were exposed to UVB light (120 mJ/cm<sup>2</sup>
) or non-UVB light and post-cultured for 24 h. Gene expression of TYR was determined by real-time quantitative PCR assay (A, B). *: p<0.05; **: p<0.01 as compared to its non-UVB control (a) or non-α-Syn control (b). The protein levels of TYR were determined by western blot assay (C, D).</p>
</caption>
<graphic xlink:href="pone.0045183.g005"></graphic>
</fig>
</sec>
</sec>
<sec id="s4"><title>Discussion</title>
<p>UVR–induced DNA damage is considered as one of the key pathogenic mechanisms underlying the development of melanoma <xref ref-type="bibr" rid="pone.0045183-Gilchrest1">[12]</xref>
, and UVR-induced melanin synthesis is a major physiological defense against solar irradiation-induced DNA damage by preventing the penetration of UVR and by absorbing or scattering the UVR <xref ref-type="bibr" rid="pone.0045183-Harbour1">[14]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Dwyer1">[15]</xref>
, <xref ref-type="bibr" rid="pone.0045183-Baldea1">[49]</xref>
. The induction of melanin synthesis, stimulation of TYR activity, and triggering the MSH/melanocortin 1 receptor (MC1R)/cAMP pathway are critical steps in UVR-induced melanogenesis <xref ref-type="bibr" rid="pone.0045183-Miller1">[56]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Cui1">[58]</xref>
. Consistent with previous reports, we showed that UVB light exposure increased melanin synthesis as well as TYR activity. Our results that α-Syn expression reduced UVB light-induced increase of melanin synthesis and that the melanin content was less when melanoma cells were expressed with α-Syn indicate that α-Syn may have inhibitory effects on UVB light-induced melanin synthesis in melanoma cells, which were supported by the recent findings that α-Syn-expressed melanoma cells generate no or a very low level of melanin pigments <xref ref-type="bibr" rid="pone.0045183-Matsuo1">[31]</xref>
.</p>
<p>Melanoma cells are malignant tumor cells of melanocytes, expressing mainly the rate-limiting enzyme TYR involved in the biosynthesis of melanin <xref ref-type="bibr" rid="pone.0045183-Ando1">[34]</xref>
. Consistent with the results from melanin assay, α-Syn over-expression demonstrated a less increase of TYR activity as compared to that in non-α-Syn-expressed control cells, indicating that α-Syn may also inhibit UVB light-induced activation of TYR enzyme. The interaction between α-Syn and TYR could be the explanation for the reduction of UVB light-induced increase of melanin synthesis and TYR activity in α-Syn-expressed melanoma cells (<xref ref-type="fig" rid="pone-0045183-g006">Fig. 6</xref>
).</p>
<fig id="pone-0045183-g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0045183.g006</object-id>
<label>Figure 6</label>
<caption><title>Flow chat of the linkage between PD and melanoma mediated by α-Syn.</title>
<p>In skin melanocytes, UVR causes DNA damage, leading to the initiation of melanoma. UVR also induces melanin synthesis which is catalyzed by TYR. Increased melanin prevents UVR-induced DNA damage, reducing the vulnerability to development of melanoma. α-Syn expression in skin melanocytes may interact with TYR, inhibiting UVR-induced TYR activation, leading to the reduction of melanin synthesis, which may enhance the susceptibility of skin melanocytes to develop melanoma. In brain dopaminergic neurons, impaired degradation of α-Syn or α-Syn multiplications causes accumulation/aggregation of α-Syn, leading to the loss of α-Syn function, thereafter, the decrease of DA release and increase of cellular DA content, which may be converted into melanin in lysosome. The increased melanin content in dopaminergic neurons (neuromelanin) enhances the susceptibility to oxidative stress-induced neuronal injury relevant to PD.</p>
</caption>
<graphic xlink:href="pone.0045183.g006"></graphic>
</fig>
<p>Different from melanoma cells, dopaminergic neuronal cells express mainly TH enzyme involved in the biosynthesis of DA, and accordingly, neuromelanin (NM), melanin presented in dopaminergic neurons. It has been reported that accumulation of α-Syn can result in impaired SNAE-complex assembly and synaptic vesicle function <xref ref-type="bibr" rid="pone.0045183-Verkrellis1">[59]</xref>
and the loss of TH inhibition, which in turn, can reduce the release of DA and increase the content of cytosolic DA, thereafter, the increase of melanin level (<xref ref-type="fig" rid="pone-0045183-g006">Fig. 6</xref>
). We explain that UVB light-induced decrease of extra-cellular DA content in dopaminergic neuronal cells could be related to the increased synthesis of neuromelanin from cellular DA in lysosome.</p>
<p>Since NM is produced from oxyradical metabolites of monoamine neuroamine neurotransmitters including DA <xref ref-type="bibr" rid="pone.0045183-Sulzer1">[60]</xref>
, the observed increase of melanin content in α-Syn over-expressed dopaminergic neuronal SH-SY5Y and PC12 cells, cellular models relevant to PD, could be mainly explained by the increased cytosolic DA due to the loss of α-Syn function on the inhibition of TH. Our experimental result is also supported by the recent report that increased expression of α-Syn is associated with NM accumulation <xref ref-type="bibr" rid="pone.0045183-Xuan1">[61]</xref>
.</p>
<p>Although NM can interact with free iron in SN neurons, acting as a strong neuron protectant and a key factor in delaying neuron death <xref ref-type="bibr" rid="pone.0045183-Dusek1">[62]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Enochs1">[65]</xref>
, the interaction of NM with iron can also make dopaminergic nigral neurons more sensitive to oxidative stress, leading to neuronal injury <xref ref-type="bibr" rid="pone.0045183-Stepie1">[66]</xref>
–<xref ref-type="bibr" rid="pone.0045183-Nicolaus1">[69]</xref>
. Therefore, the increase of melanin in dopaminergic neurons correlates with enhanced susceptibility to oxidative stress-induced neuronal injury relevant to PD (<xref ref-type="fig" rid="pone-0045183-g006">Fig. 6</xref>
). The reports that NM enhances the toxicity of α-Syn in SK-N-SH cells <xref ref-type="bibr" rid="pone.0045183-Li1">[70]</xref>
and that the selective neurotoxicity of α-Syn is dependent on DA <xref ref-type="bibr" rid="pone.0045183-Xu1">[71]</xref>
further support that the neurotoxicity of α-Syn could be related to the increased melanin content.</p>
<p>Although our results show that UVB light exposure increases TYR gene expression, which is consistent with previous reports, we did not show an increase of TYR protein level in UVB light-exposed cells. Previous reports have suggested that TYR mRNA, melanin and protein levels do not always correlate because of multiple factors, such as proteolytic degradation system and other auto-regulatory mechanisms <xref ref-type="bibr" rid="pone.0045183-Ando2">[72]</xref>
. This may provide an explanation for the seemingly inconsistent results between the changes of TYR mRNA and TYR protein levels in our study.</p>
<p>In conclusion, α-Syn over-expression causes less increase of UVB light-induced melanin synthesis in melanoma cells and causes higher melanin levels in dopaminergic neuronal cells. These differential roles of α-Syn in the biosynthesis of melanin in melanocytes and dopaminergic neurons may be critical in the association of these two diseases. Further studies are necessary to further evaluate roles of α-Syn in UVB irradiation-induced tumorigenesis of melanoma in normal skin melanocytes and to explore possible mechanisms involved. Melanoma is the most dangerous form of skin cancers with high metastasis rate and poor prognosis. Understanding the linkage between PD and melanoma by α-Syn may draw an attention to our physicians and patients that a periodic dermatological screening for neoplastic or pre-neoplastic skin lesions as well as for skin α-Syn expression by skin biopsy in PD patients is important as to diagnose early and prevent the development of melanoma.</p>
</sec>
</body>
<back><ref-list><title>References</title>
<ref id="pone.0045183-Liu1"><label>1</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname>
<given-names>R</given-names>
</name>
, <name><surname>Gao</surname>
<given-names>X</given-names>
</name>
, <name><surname>Lu</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Chen</surname>
<given-names>H</given-names>
</name>
(<year>2011</year>
) <article-title>Meta-analysis of the relationship between Parkinson disease and melanoma</article-title>
. <source>Neurology</source>
<volume>76</volume>
: <fpage>2002</fpage>
–<lpage>2009</lpage>
<pub-id pub-id-type="pmid">21646627</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Bertoni1"><label>2</label>
<mixed-citation publication-type="journal"><name><surname>Bertoni</surname>
<given-names>JM</given-names>
</name>
, <name><surname>Arlette</surname>
<given-names>JP</given-names>
</name>
, <name><surname>Fernandez</surname>
<given-names>HH</given-names>
</name>
, <name><surname>Fitzer-Attas</surname>
<given-names>C</given-names>
</name>
, <name><surname>Frei</surname>
<given-names>K</given-names>
</name>
, <etal>et al</etal>
(<year>2010</year>
) <article-title>Increased melanoma risk in Parkinson disease: a prospective clinicopathological study</article-title>
. <source>Arch Neurol</source>
<volume>67</volume>
: <fpage>347</fpage>
–<lpage>352</lpage>
<pub-id pub-id-type="pmid">20212233</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Ferreira1"><label>3</label>
<mixed-citation publication-type="journal"><name><surname>Ferreira</surname>
<given-names>JJ</given-names>
</name>
, <name><surname>Neutel</surname>
<given-names>D</given-names>
</name>
, <name><surname>Mestre</surname>
<given-names>T</given-names>
</name>
, <name><surname>Coelho</surname>
<given-names>M</given-names>
</name>
, <name><surname>Rosa</surname>
<given-names>MM</given-names>
</name>
, <etal>et al</etal>
(<year>2010</year>
) <article-title>Skin cancer and Parkinson’s disease</article-title>
. <source>Mov Disord</source>
<volume>25</volume>
: <fpage>139</fpage>
–<lpage>148</lpage>
<pub-id pub-id-type="pmid">20063399</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Gao1"><label>4</label>
<mixed-citation publication-type="journal"><name><surname>Gao</surname>
<given-names>X</given-names>
</name>
, <name><surname>Simon</surname>
<given-names>KC</given-names>
</name>
, <name><surname>Han</surname>
<given-names>J</given-names>
</name>
, <name><surname>Schwarzschild</surname>
<given-names>MA</given-names>
</name>
, <name><surname>Ascherio</surname>
<given-names>A</given-names>
</name>
(<year>2009</year>
) <article-title>Family history of melanoma and Parkinson disease risk</article-title>
. <source>Neurology</source>
<volume>73</volume>
: <fpage>1286</fpage>
–<lpage>1291</lpage>
<pub-id pub-id-type="pmid">19841380</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Driver1"><label>5</label>
<mixed-citation publication-type="journal"><name><surname>Driver</surname>
<given-names>JA</given-names>
</name>
, <name><surname>Logroscino</surname>
<given-names>G</given-names>
</name>
, <name><surname>Buring</surname>
<given-names>JE</given-names>
</name>
, <name><surname>Gaziano</surname>
<given-names>JM</given-names>
</name>
, <name><surname>Kurth</surname>
<given-names>T</given-names>
</name>
(<year>2007</year>
) <article-title>A prospective cohort study of cancer incidence following the diagnosis of Parkinson’s disease</article-title>
. <source>Cancer Epidemiol Biomarkers Prev</source>
<volume>16</volume>
: <fpage>1260</fpage>
–<lpage>1265</lpage>
<pub-id pub-id-type="pmid">17548694</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Pan1"><label>6</label>
<mixed-citation publication-type="journal"><name><surname>Pan</surname>
<given-names>T</given-names>
</name>
, <name><surname>Li</surname>
<given-names>X</given-names>
</name>
, <name><surname>Jankovic</surname>
<given-names>J</given-names>
</name>
(<year>2011</year>
) <article-title>The association between Parkinson’s disease and melanoma</article-title>
. <source>Int J Cancer</source>
<volume>128</volume>
: <fpage>2251</fpage>
–<lpage>2260</lpage>
<pub-id pub-id-type="pmid">21207412</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-PlunFavreau1"><label>7</label>
<mixed-citation publication-type="journal"><name><surname>Plun-Favreau</surname>
<given-names>H</given-names>
</name>
, <name><surname>Lewis</surname>
<given-names>PA</given-names>
</name>
, <name><surname>Hardy</surname>
<given-names>J</given-names>
</name>
, <name><surname>Martins</surname>
<given-names>LM</given-names>
</name>
, <name><surname>Wood</surname>
<given-names>NW</given-names>
</name>
(<year>2010</year>
) <article-title>Cancer and neurodegeneration: between the devil and the deep blue sea</article-title>
. <source>PLoS Genet</source>
<volume>6</volume>
: <fpage>e1001257</fpage>
<pub-id pub-id-type="pmid">21203498</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-PaisnRuiz1"><label>8</label>
<mixed-citation publication-type="journal"><name><surname>Paisán-Ruiz</surname>
<given-names>C</given-names>
</name>
, <name><surname>Houlden</surname>
<given-names>H</given-names>
</name>
(<year>2010</year>
) <article-title>Common pathogenic in melanoma and Parkinson disease</article-title>
. <source>Neurology</source>
<volume>75</volume>
: <fpage>1653</fpage>
–<lpage>1655</lpage>
<pub-id pub-id-type="pmid">21041788</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Inzelberg1"><label>9</label>
<mixed-citation publication-type="journal"><name><surname>Inzelberg</surname>
<given-names>R</given-names>
</name>
, <name><surname>Israeli-Korn</surname>
<given-names>SD</given-names>
</name>
(<year>2009</year>
) <article-title>The particular relationship between Parkinson’s disease and malignancy: a focus on skin cancers</article-title>
. <source>J Neural Transm</source>
<volume>116</volume>
: <fpage>1503</fpage>
–<lpage>1507</lpage>
<pub-id pub-id-type="pmid">19789839</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Inzelberg2"><label>10</label>
<mixed-citation publication-type="journal"><name><surname>Inzelberg</surname>
<given-names>R</given-names>
</name>
, <name><surname>Jankovic</surname>
<given-names>J</given-names>
</name>
(<year>2007</year>
) <article-title>Are Parkinson disease patients protected from some but not all cancers?</article-title>
<source>Neurology</source>
<volume>69</volume>
: <fpage>1542</fpage>
–<lpage>1550</lpage>
<pub-id pub-id-type="pmid">17699801</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Izykowska1"><label>11</label>
<mixed-citation publication-type="journal"><name><surname>Izykowska</surname>
<given-names>I</given-names>
</name>
, <name><surname>Gebarowska</surname>
<given-names>E</given-names>
</name>
, <name><surname>Cegielski</surname>
<given-names>M</given-names>
</name>
, <name><surname>Podhorska-Okolow</surname>
<given-names>M</given-names>
</name>
, <name><surname>Piotrowska</surname>
<given-names>A</given-names>
</name>
, <etal>et al</etal>
(<year>2009</year>
) <article-title>Effect of melatonin on melanoma cells subjected to UVA and UVB radiation in In vitro studies</article-title>
. <source>In Vivo</source>
<volume>23</volume>
: <fpage>733</fpage>
–<lpage>738</lpage>
<pub-id pub-id-type="pmid">19779108</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Gilchrest1"><label>12</label>
<mixed-citation publication-type="journal"><name><surname>Gilchrest</surname>
<given-names>BA</given-names>
</name>
, <name><surname>Eller</surname>
<given-names>MS</given-names>
</name>
, <name><surname>Geller</surname>
<given-names>AC</given-names>
</name>
, <name><surname>Yaar</surname>
<given-names>M</given-names>
</name>
(<year>1999</year>
) <article-title>The pathogenesis of melanoma induced by ultraviolet radiation</article-title>
. <source>N Engl J Med</source>
<volume>340</volume>
: <fpage>1341</fpage>
–<lpage>1348</lpage>
<pub-id pub-id-type="pmid">10219070</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Jiang1"><label>13</label>
<mixed-citation publication-type="journal"><name><surname>Jiang</surname>
<given-names>W</given-names>
</name>
, <name><surname>Ananthaswamy</surname>
<given-names>HN</given-names>
</name>
, <name><surname>Muller</surname>
<given-names>HK</given-names>
</name>
, <name><surname>Kripke</surname>
<given-names>ML</given-names>
</name>
(<year>1999</year>
) <article-title>p53 protects against skin cancer induction by UV-B radiation</article-title>
. <source>Oncogene</source>
<volume>18</volume>
: <fpage>4247</fpage>
–<lpage>4253</lpage>
<pub-id pub-id-type="pmid">10435637</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Harbour1"><label>14</label>
<mixed-citation publication-type="journal"><name><surname>Harbour</surname>
<given-names>JW</given-names>
</name>
, <name><surname>Brantley</surname>
<given-names>MA</given-names>
<suffix>Jr</suffix>
</name>
, <name><surname>Hollingsworth</surname>
<given-names>H</given-names>
</name>
, <name><surname>Gordon</surname>
<given-names>M</given-names>
</name>
(<year>2004</year>
) <article-title>Association between choroidal pigmentation and posterior uveal melanoma in a white population</article-title>
. <source>Br J Ophthalmol</source>
<volume>88</volume>
: <fpage>39</fpage>
–<lpage>43</lpage>
<pub-id pub-id-type="pmid">14693770</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Dwyer1"><label>15</label>
<mixed-citation publication-type="journal"><name><surname>Dwyer</surname>
<given-names>T</given-names>
</name>
, <name><surname>Blizzard</surname>
<given-names>L</given-names>
</name>
, <name><surname>Ashbolt</surname>
<given-names>R</given-names>
</name>
, <name><surname>Plumb</surname>
<given-names>J</given-names>
</name>
, <name><surname>Berwick</surname>
<given-names>M</given-names>
</name>
, <etal>et al</etal>
(<year>2002</year>
) <article-title>Cutaneous melanin density measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma and squamous cell carcinoma of the skin</article-title>
. <source>Am J Epidemiol</source>
<volume>155</volume>
: <fpage>614</fpage>
–<lpage>621</lpage>
<pub-id pub-id-type="pmid">11914188</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Aitken1"><label>16</label>
<mixed-citation publication-type="journal"><name><surname>Aitken</surname>
<given-names>JF</given-names>
</name>
, <name><surname>Elwood</surname>
<given-names>JM</given-names>
</name>
, <name><surname>Lowe</surname>
<given-names>JB</given-names>
</name>
, <name><surname>Firman</surname>
<given-names>DW</given-names>
</name>
, <name><surname>Balanda</surname>
<given-names>KP</given-names>
</name>
, <etal>et al</etal>
(<year>2002</year>
) <article-title>A randomised trial of population screening for melanoma</article-title>
. <source>J Med Screen</source>
<volume>9</volume>
: <fpage>33</fpage>
–<lpage>37</lpage>
<pub-id pub-id-type="pmid">11943795</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Weinstock1"><label>17</label>
<mixed-citation publication-type="journal"><name><surname>Weinstock</surname>
<given-names>MA</given-names>
</name>
(<year>2001</year>
) <article-title>Epidemiology, etiology, and control of melanoma</article-title>
. <source>Med Health R I</source>
<volume>84</volume>
: <fpage>234</fpage>
–<lpage>236</lpage>
<pub-id pub-id-type="pmid">11482278</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-WrightWillis1"><label>18</label>
<mixed-citation publication-type="journal"><name><surname>Wright Willis</surname>
<given-names>A</given-names>
</name>
, <name><surname>Evanoff</surname>
<given-names>BA</given-names>
</name>
, <name><surname>Lian</surname>
<given-names>M</given-names>
</name>
, <name><surname>Criswell</surname>
<given-names>SR</given-names>
</name>
, <name><surname>Racette</surname>
<given-names>BA</given-names>
</name>
(<year>2010</year>
) <article-title>Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries</article-title>
. <source>Neuroepidemiology</source>
<volume>34</volume>
: <fpage>143</fpage>
–<lpage>151</lpage>
<pub-id pub-id-type="pmid">20090375</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Dahodwala1"><label>19</label>
<mixed-citation publication-type="journal"><name><surname>Dahodwala</surname>
<given-names>N</given-names>
</name>
, <name><surname>Siderowf</surname>
<given-names>A</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>M</given-names>
</name>
, <name><surname>Noll</surname>
<given-names>E</given-names>
</name>
, <name><surname>Stern</surname>
<given-names>M</given-names>
</name>
, <etal>et al</etal>
(<year>2009</year>
) <article-title>Racial differences in the diagnosis of Parkinson’s disease</article-title>
. <source>Mov Disord</source>
<volume>24</volume>
: <fpage>1200</fpage>
–<lpage>1205</lpage>
<pub-id pub-id-type="pmid">19412929</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Elbaz1"><label>20</label>
<mixed-citation publication-type="journal"><name><surname>Elbaz</surname>
<given-names>A</given-names>
</name>
, <name><surname>Moisan</surname>
<given-names>F</given-names>
</name>
(<year>2008</year>
) <article-title>Update in the epidemiology of Parkinson’s disease</article-title>
. <source>Curr Opin Neurol</source>
<volume>21</volume>
: <fpage>454</fpage>
–<lpage>460</lpage>
<pub-id pub-id-type="pmid">18607207</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Shulman1"><label>21</label>
<mixed-citation publication-type="journal"><name><surname>Shulman</surname>
<given-names>JM</given-names>
</name>
, <name><surname>De Jager</surname>
<given-names>PL</given-names>
</name>
, <name><surname>Feany</surname>
<given-names>MB</given-names>
</name>
(<year>2011</year>
) <article-title>Parkinson’s disease: genetics and pathogenesis</article-title>
. <source>Annu Rev Pathol</source>
<volume>6</volume>
: <fpage>193</fpage>
–<lpage>222</lpage>
<pub-id pub-id-type="pmid">21034221</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Singleton1"><label>22</label>
<mixed-citation publication-type="journal"><name><surname>Singleton</surname>
<given-names>AB</given-names>
</name>
, <name><surname>Farrer</surname>
<given-names>M</given-names>
</name>
, <name><surname>Johnson</surname>
<given-names>J</given-names>
</name>
, <name><surname>Singleton</surname>
<given-names>A</given-names>
</name>
, <name><surname>Hague</surname>
<given-names>S</given-names>
</name>
, <etal>et al</etal>
(<year>2003</year>
) <article-title>Alpha-Syn locus triplication causes Parkinson’s disease</article-title>
. <source>Science</source>
<volume>302</volume>
: <fpage>841</fpage>
<pub-id pub-id-type="pmid">14593171</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Polymeropoulos1"><label>23</label>
<mixed-citation publication-type="journal"><name><surname>Polymeropoulos</surname>
<given-names>MH</given-names>
</name>
, <name><surname>Lavedan</surname>
<given-names>C</given-names>
</name>
, <name><surname>Leroy</surname>
<given-names>E</given-names>
</name>
, <name><surname>Ide</surname>
<given-names>SE</given-names>
</name>
, <name><surname>Dehejia</surname>
<given-names>A</given-names>
</name>
, <etal>et al</etal>
(<year>1997</year>
) <article-title>Mutation in the alpha-Syn gene identified in families with Parkinson’s disease</article-title>
. <source>Science</source>
<volume>276</volume>
: <fpage>2045</fpage>
–<lpage>2047</lpage>
<pub-id pub-id-type="pmid">9197268</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Shishido1"><label>24</label>
<mixed-citation publication-type="journal"><name><surname>Shishido</surname>
<given-names>T</given-names>
</name>
, <name><surname>Ikemura</surname>
<given-names>M</given-names>
</name>
, <name><surname>Obi</surname>
<given-names>T</given-names>
</name>
, <name><surname>Yamazaki</surname>
<given-names>K</given-names>
</name>
, <name><surname>Terada</surname>
<given-names>T</given-names>
</name>
, <etal>et al</etal>
(<year>2010</year>
) <article-title>Alpha-Syn accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure</article-title>
. <source>Neurology</source>
<volume>74</volume>
: <fpage>608</fpage>
–<lpage>610</lpage>
<pub-id pub-id-type="pmid">20157164</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Wakabayashi1"><label>25</label>
<mixed-citation publication-type="journal"><name><surname>Wakabayashi</surname>
<given-names>K</given-names>
</name>
, <name><surname>Mori</surname>
<given-names>F</given-names>
</name>
, <name><surname>Tanji</surname>
<given-names>K</given-names>
</name>
, <name><surname>Orimo</surname>
<given-names>S</given-names>
</name>
, <name><surname>Takahashi</surname>
<given-names>H</given-names>
</name>
(<year>2010</year>
) <article-title>Involvement of the peripheral nervous system in Synopathies, tauopathies and other neurodegenerative proteinopathies of the brain</article-title>
. <source>Acta Neuropathol</source>
<volume>120</volume>
: <fpage>1</fpage>
–<lpage>12</lpage>
<pub-id pub-id-type="pmid">20532896</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Ikemura1"><label>26</label>
<mixed-citation publication-type="journal"><name><surname>Ikemura</surname>
<given-names>M</given-names>
</name>
, <name><surname>Saito</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Sengoku</surname>
<given-names>R</given-names>
</name>
, <name><surname>Sakiyama</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Hatsuta</surname>
<given-names>H</given-names>
</name>
, <etal>et al</etal>
(<year>2008</year>
) <article-title>Lewy body pathology involves cutaneous nerves</article-title>
. <source>J Neuropathol Exp Neurol</source>
<volume>67</volume>
: <fpage>945</fpage>
–<lpage>953</lpage>
<pub-id pub-id-type="pmid">18800013</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Luk1"><label>27</label>
<mixed-citation publication-type="journal"><name><surname>Luk</surname>
<given-names>KC</given-names>
</name>
, <name><surname>Kehm</surname>
<given-names>VM</given-names>
</name>
, <name><surname>Zhang</surname>
<given-names>B</given-names>
</name>
, <name><surname>O’Brien</surname>
<given-names>P</given-names>
</name>
, <name><surname>Trojanowski</surname>
<given-names>JQ</given-names>
</name>
, <etal>et al</etal>
(<year>2012</year>
) <article-title>Intracerebralinoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice</article-title>
. <source>J Exp Med</source>
<volume>209</volume>
: <fpage>975</fpage>
–<lpage>986</lpage>
<pub-id pub-id-type="pmid">22508839</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Olanow1"><label>28</label>
<mixed-citation publication-type="journal"><name><surname>Olanow</surname>
<given-names>CW</given-names>
</name>
, <name><surname>Prusiner</surname>
<given-names>SB</given-names>
</name>
(<year>2009</year>
) <article-title>Is Parkinson’s disease a prion disorder?</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>106</volume>
: <fpage>12571</fpage>
–<lpage>12572</lpage>
<pub-id pub-id-type="pmid">19666621</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Bruening1"><label>29</label>
<mixed-citation publication-type="journal"><name><surname>Bruening</surname>
<given-names>W</given-names>
</name>
, <name><surname>Giasson</surname>
<given-names>BI</given-names>
</name>
, <name><surname>Klein-Szanto</surname>
<given-names>AJ</given-names>
</name>
, <name><surname>Lee</surname>
<given-names>VM</given-names>
</name>
, <name><surname>Trojanowski</surname>
<given-names>JQ</given-names>
</name>
, <etal>et al</etal>
(<year>2000</year>
) <article-title>Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary</article-title>
. <source>Cancer</source>
<volume>88</volume>
: <fpage>2154</fpage>
–<lpage>2163</lpage>
<pub-id pub-id-type="pmid">10813729</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Ye1"><label>30</label>
<mixed-citation publication-type="journal"><name><surname>Ye</surname>
<given-names>Q</given-names>
</name>
, <name><surname>Wang</surname>
<given-names>TF</given-names>
</name>
, <name><surname>Peng</surname>
<given-names>YF</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>J</given-names>
</name>
, <name><surname>Feng</surname>
<given-names>B</given-names>
</name>
, <etal>et al</etal>
(<year>2010</year>
) <article-title>Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease</article-title>
. <source>Oncol Rep</source>
<volume>23</volume>
: <fpage>429</fpage>
–<lpage>436</lpage>
<pub-id pub-id-type="pmid">20043104</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Matsuo1"><label>31</label>
<mixed-citation publication-type="journal"><name><surname>Matsuo</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Kamitani</surname>
<given-names>T</given-names>
</name>
(<year>2010</year>
) <article-title>Parkinson’s disease-related protein, alpha-Syn, in malignant melanoma</article-title>
. <source>PLoS One</source>
<volume>5</volume>
: <fpage>10481</fpage>
</mixed-citation>
</ref>
<ref id="pone.0045183-Peng1"><label>32</label>
<mixed-citation publication-type="journal"><name><surname>Peng</surname>
<given-names>X</given-names>
</name>
, <name><surname>Tehranian</surname>
<given-names>R</given-names>
</name>
, <name><surname>Dietrich</surname>
<given-names>P</given-names>
</name>
, <name><surname>Stefanis</surname>
<given-names>L</given-names>
</name>
, <name><surname>Perez</surname>
<given-names>RG</given-names>
</name>
(<year>2005</year>
) <article-title>Alpha-Syn activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells</article-title>
. <source>J Cell Sci 118(Pt</source>
<volume>15)</volume>
: <fpage>3523</fpage>
–<lpage>3530</lpage>
</mixed-citation>
</ref>
<ref id="pone.0045183-Perez1"><label>33</label>
<mixed-citation publication-type="journal"><name><surname>Perez</surname>
<given-names>RG</given-names>
</name>
, <name><surname>Waymire</surname>
<given-names>JC</given-names>
</name>
, <name><surname>Lin</surname>
<given-names>E</given-names>
</name>
, <name><surname>Liu</surname>
<given-names>JJ</given-names>
</name>
, <name><surname>Guo</surname>
<given-names>F</given-names>
</name>
, <etal>et al</etal>
(<year>2002</year>
) <article-title>A role for alpha-Syn in the regulation of dopamine biosynthesis</article-title>
. <source>J Neurosci</source>
<volume>22</volume>
: <fpage>3090</fpage>
–<lpage>3099</lpage>
<pub-id pub-id-type="pmid">11943812</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Ando1"><label>34</label>
<mixed-citation publication-type="journal"><name><surname>Ando</surname>
<given-names>H</given-names>
</name>
, <name><surname>Kondoh</surname>
<given-names>H</given-names>
</name>
, <name><surname>Ichihashi</surname>
<given-names>M</given-names>
</name>
, <name><surname>Hearing</surname>
<given-names>VJ</given-names>
</name>
(<year>2007</year>
) <article-title>Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase</article-title>
. <source>J Invest Dermatol</source>
<volume>127</volume>
: <fpage>751</fpage>
–<lpage>761</lpage>
<pub-id pub-id-type="pmid">17218941</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Tessari1"><label>35</label>
<mixed-citation publication-type="journal"><name><surname>Tessari</surname>
<given-names>I</given-names>
</name>
, <name><surname>Bisaglia</surname>
<given-names>M</given-names>
</name>
, <name><surname>Valle</surname>
<given-names>F</given-names>
</name>
, <name><surname>Samorì</surname>
<given-names>B</given-names>
</name>
, <name><surname>Bergantino</surname>
<given-names>E</given-names>
</name>
, <etal>et al</etal>
(<year>2008</year>
) <article-title>The reaction of alpha-Syn with tyrosinase: possible implications for Parkinson disease</article-title>
. <source>J Biol Chem</source>
<volume>283</volume>
: <fpage>16808</fpage>
–<lpage>16817</lpage>
<pub-id pub-id-type="pmid">18390556</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Liu2"><label>36</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname>
<given-names>D</given-names>
</name>
, <name><surname>Jin</surname>
<given-names>L</given-names>
</name>
, <name><surname>Wang</surname>
<given-names>H</given-names>
</name>
, <name><surname>Zhao</surname>
<given-names>H</given-names>
</name>
, <name><surname>Zhao</surname>
<given-names>C</given-names>
</name>
, <etal>et al</etal>
(<year>2008</year>
) <article-title>Silencing alpha-Syn gene expression enhances tyrosine hydroxylase activity in MN9D cells</article-title>
. <source>Neurochem Res</source>
<volume>33</volume>
: <fpage>1401</fpage>
–<lpage>1409</lpage>
<pub-id pub-id-type="pmid">18357527</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Bellei1"><label>37</label>
<mixed-citation publication-type="journal"><name><surname>Bellei</surname>
<given-names>B</given-names>
</name>
, <name><surname>Maresca</surname>
<given-names>V</given-names>
</name>
, <name><surname>Flori</surname>
<given-names>E</given-names>
</name>
, <name><surname>Pitisci</surname>
<given-names>A</given-names>
</name>
, <name><surname>Larue</surname>
<given-names>L</given-names>
</name>
, <etal>et al</etal>
(<year>2010</year>
) <article-title>p38 regulates pigmentation via proteasomal degradation of tyrosinase</article-title>
. <source>J Biol Chem</source>
<volume>285</volume>
: <fpage>7288</fpage>
–<lpage>7299</lpage>
<pub-id pub-id-type="pmid">20053998</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Duffy1"><label>38</label>
<mixed-citation publication-type="journal"><name><surname>Duffy</surname>
<given-names>DL</given-names>
</name>
, <name><surname>Zhao</surname>
<given-names>ZZ</given-names>
</name>
, <name><surname>Sturm</surname>
<given-names>RA</given-names>
</name>
, <name><surname>Hayward</surname>
<given-names>NK</given-names>
</name>
, <name><surname>Martin</surname>
<given-names>NG</given-names>
</name>
, <etal>et al</etal>
(<year>2010</year>
) <article-title>Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma</article-title>
. <source>J Invest Dermatol</source>
<volume>130</volume>
: <fpage>520</fpage>
–<lpage>528</lpage>
<pub-id pub-id-type="pmid">19710684</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Wu1"><label>39</label>
<mixed-citation publication-type="journal"><name><surname>Wu</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Li</surname>
<given-names>X</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>W</given-names>
</name>
, <name><surname>Jankovic</surname>
<given-names>J</given-names>
</name>
, <name><surname>Le</surname>
<given-names>W</given-names>
</name>
, <etal>et al</etal>
(<year>2010</year>
) <article-title>Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells</article-title>
. <source>Neurochem Int</source>
<volume>57</volume>
: <fpage>198</fpage>
–<lpage>205</lpage>
<pub-id pub-id-type="pmid">20546814</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Pan2"><label>40</label>
<mixed-citation publication-type="journal"><name><surname>Pan</surname>
<given-names>T</given-names>
</name>
, <name><surname>Rawal</surname>
<given-names>P</given-names>
</name>
, <name><surname>Wu</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>W</given-names>
</name>
, <name><surname>Jankovic</surname>
<given-names>J</given-names>
</name>
, <etal>et al</etal>
(<year>2009</year>
) <article-title>Rapamycin protects against rotenone-induced apoptosis through autophagy induction</article-title>
. <source>Neuroscience</source>
<volume>164</volume>
: <fpage>541</fpage>
–<lpage>551</lpage>
<pub-id pub-id-type="pmid">19682553</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Sarkar1"><label>41</label>
<mixed-citation publication-type="journal"><name><surname>Sarkar</surname>
<given-names>S</given-names>
</name>
, <name><surname>Davies</surname>
<given-names>JE</given-names>
</name>
, <name><surname>Huang</surname>
<given-names>Z</given-names>
</name>
, <name><surname>Tunnacliffe</surname>
<given-names>A</given-names>
</name>
, <name><surname>Rubinsztein</surname>
<given-names>DC</given-names>
</name>
(<year>2007</year>
) <article-title>Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein</article-title>
. <source>J Biol Chem</source>
<volume>282</volume>
: <fpage>5641</fpage>
–<lpage>5652</lpage>
<pub-id pub-id-type="pmid">17182613</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Sarkar2"><label>42</label>
<mixed-citation publication-type="journal"><name><surname>Sarkar</surname>
<given-names>S</given-names>
</name>
, <name><surname>Ravikumar</surname>
<given-names>B</given-names>
</name>
, <name><surname>Rubinsztein</surname>
<given-names>DC</given-names>
</name>
(<year>2009</year>
) <article-title>Autophagic clearance of aggregate-prone proteins associated with neurodegeneration</article-title>
. <source>Methods Enzymol</source>
<volume>453</volume>
: <fpage>83</fpage>
–<lpage>110</lpage>
<pub-id pub-id-type="pmid">19216903</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Pan3"><label>43</label>
<mixed-citation publication-type="journal"><name><surname>Pan</surname>
<given-names>T</given-names>
</name>
, <name><surname>Zhu</surname>
<given-names>W</given-names>
</name>
, <name><surname>Zhao</surname>
<given-names>H</given-names>
</name>
, <name><surname>Deng</surname>
<given-names>H</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>W</given-names>
</name>
, <etal>et al</etal>
(<year>2008</year>
) <article-title>Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo</article-title>
. <source>Brain Res</source>
<volume>1222</volume>
: <fpage>222</fpage>
–<lpage>229</lpage>
<pub-id pub-id-type="pmid">18579122</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Jiang2"><label>44</label>
<mixed-citation publication-type="journal"><name><surname>Jiang</surname>
<given-names>CT</given-names>
</name>
, <name><surname>Chang</surname>
<given-names>JY</given-names>
</name>
(<year>2007</year>
) <article-title>Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties</article-title>
. <source>Biochemistry</source>
<volume>46</volume>
: <fpage>602</fpage>
–<lpage>609</lpage>
<pub-id pub-id-type="pmid">17209570</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Wu2"><label>45</label>
<mixed-citation publication-type="journal"><name><surname>Wu</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Li</surname>
<given-names>X</given-names>
</name>
, <name><surname>Zhu</surname>
<given-names>J</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>W</given-names>
</name>
, <name><surname>Le</surname>
<given-names>W</given-names>
</name>
, <etal>et al</etal>
(<year>2011</year>
) <article-title>Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease</article-title>
. <source>NeuroSignals</source>
<volume>19(3)</volume>
: <fpage>163</fpage>
–<lpage>174</lpage>
<pub-id pub-id-type="pmid">21778691</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Izykowska2"><label>46</label>
<mixed-citation publication-type="journal"><name><surname>Izykowska</surname>
<given-names>I</given-names>
</name>
, <name><surname>Gebarowska</surname>
<given-names>E</given-names>
</name>
, <name><surname>Cegielski</surname>
<given-names>M</given-names>
</name>
, <name><surname>Podhorska-Okolow</surname>
<given-names>M</given-names>
</name>
, <name><surname>Piotrowska</surname>
<given-names>A</given-names>
</name>
, <etal>et al</etal>
(<year>2009</year>
) <article-title>Effect of melatonin on melanoma cells subjected to UVA and UVB radiation in In vitro studies</article-title>
. <source>In Vivo</source>
<volume>23</volume>
: <fpage>733</fpage>
–<lpage>738</lpage>
<pub-id pub-id-type="pmid">19779108</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Gebhardt1"><label>47</label>
<mixed-citation publication-type="journal"><name><surname>Gebhardt</surname>
<given-names>C</given-names>
</name>
, <name><surname>Averbeck</surname>
<given-names>M</given-names>
</name>
, <name><surname>Viertel</surname>
<given-names>A</given-names>
</name>
, <name><surname>Kauer</surname>
<given-names>F</given-names>
</name>
, <name><surname>Saalbach</surname>
<given-names>A</given-names>
</name>
, <etal>et al</etal>
(<year>2007</year>
) <article-title>Ultraviolet-B irradiation enhances melanoma cell motility via induction of autocrine interleukin 8 secretion</article-title>
. <source>Exp Dermatol</source>
<volume>16</volume>
: <fpage>636</fpage>
–<lpage>643</lpage>
<pub-id pub-id-type="pmid">17620090</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Pan4"><label>48</label>
<mixed-citation publication-type="journal"><name><surname>Pan</surname>
<given-names>T</given-names>
</name>
, <name><surname>Kondo</surname>
<given-names>S</given-names>
</name>
, <name><surname>Zhu</surname>
<given-names>W</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>W</given-names>
</name>
, <name><surname>Jankovic</surname>
<given-names>J</given-names>
</name>
, <etal>et al</etal>
(<year>2008</year>
) <article-title>Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement</article-title>
. <source>Neurobiol Dis</source>
<volume>32</volume>
: <fpage>16</fpage>
–<lpage>25</lpage>
<pub-id pub-id-type="pmid">18640276</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Baldea1"><label>49</label>
<mixed-citation publication-type="journal"><name><surname>Baldea</surname>
<given-names>I</given-names>
</name>
, <name><surname>Mocanl</surname>
<given-names>T</given-names>
</name>
, <name><surname>Cosgarea</surname>
<given-names>R</given-names>
</name>
(<year>2009</year>
) <article-title>The role of ultrviolet radiation and tyrosine stimulated melanogenesis in the induction of oxidative stress alterations in fair skin melanocytes</article-title>
. <source>Exp Oncol</source>
<volume>31</volume>
: <fpage>200</fpage>
–<lpage>208</lpage>
<pub-id pub-id-type="pmid">20010534</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Bellei2"><label>50</label>
<mixed-citation publication-type="journal"><name><surname>Bellei</surname>
<given-names>B</given-names>
</name>
, <name><surname>Flori</surname>
<given-names>E</given-names>
</name>
, <name><surname>Izzo</surname>
<given-names>E</given-names>
</name>
, <name><surname>Maresca</surname>
<given-names>V</given-names>
</name>
, <name><surname>Picardo</surname>
<given-names>M</given-names>
</name>
(<year>2008</year>
) <article-title>GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes</article-title>
. <source>Cell Signal</source>
<volume>20</volume>
: <fpage>1750</fpage>
–<lpage>1761</lpage>
<pub-id pub-id-type="pmid">18602000</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Aoki1"><label>51</label>
<mixed-citation publication-type="journal"><name><surname>Aoki</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Tanigawa</surname>
<given-names>T</given-names>
</name>
, <name><surname>Abe</surname>
<given-names>H</given-names>
</name>
, <name><surname>Fujiwara</surname>
<given-names>Y</given-names>
</name>
(<year>2007</year>
) <article-title>Melanogenesis inhibition by an oolong tea extract in b16 mouse melanoma cells and UV-induced skin pigmentation in brownish guinea pigs</article-title>
. <source>Biosci Biotechnol Biochem</source>
<volume>71</volume>
: <fpage>1879</fpage>
–<lpage>1885</lpage>
<pub-id pub-id-type="pmid">17690471</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Le1"><label>52</label>
<mixed-citation publication-type="journal"><name><surname>Le</surname>
<given-names>W</given-names>
</name>
, <name><surname>Pan</surname>
<given-names>T</given-names>
</name>
, <name><surname>Huang</surname>
<given-names>M</given-names>
</name>
, <name><surname>Xu</surname>
<given-names>P</given-names>
</name>
, <name><surname>Xie</surname>
<given-names>W</given-names>
</name>
, <etal>et al</etal>
(<year>2008</year>
) <article-title>Decreased NURR1 gene expression in patients with Parkinson’s disease</article-title>
. <source>J Neurol Sci</source>
<volume>273</volume>
: <fpage>29</fpage>
–<lpage>33</lpage>
<pub-id pub-id-type="pmid">18684475</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Lindsey1"><label>53</label>
<mixed-citation publication-type="journal"><name><surname>Lindsey</surname>
<given-names>JD</given-names>
</name>
, <name><surname>Jones</surname>
<given-names>HL</given-names>
</name>
, <name><surname>Hewitt</surname>
<given-names>EG</given-names>
</name>
, <name><surname>Angert</surname>
<given-names>M</given-names>
</name>
, <name><surname>Weinreb</surname>
<given-names>RN</given-names>
</name>
(<year>2001</year>
) <article-title>Induction of tyrosinase gene transcription in human Iris organ cultures exposed to latanoprost</article-title>
. <source>Arch ophthalmol</source>
<volume>119</volume>
: <fpage>853</fpage>
–<lpage>860</lpage>
<pub-id pub-id-type="pmid">11405836</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Halaban1"><label>54</label>
<mixed-citation publication-type="journal"><name><surname>Halaban</surname>
<given-names>R</given-names>
</name>
, <name><surname>Cheng</surname>
<given-names>E</given-names>
</name>
, <name><surname>Zhang</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Moellmann</surname>
<given-names>G</given-names>
</name>
, <name><surname>Hanlon</surname>
<given-names>D</given-names>
</name>
, <etal>et al</etal>
(<year>1997</year>
) <article-title>Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells Proc Natl Acad Sci U S A</article-title>
. <volume>94</volume>
: <fpage>6210</fpage>
–<lpage>6215</lpage>
</mixed-citation>
</ref>
<ref id="pone.0045183-Iozumi1"><label>55</label>
<mixed-citation publication-type="journal"><name><surname>Iozumi</surname>
<given-names>K</given-names>
</name>
, <name><surname>Hoganson</surname>
<given-names>GE</given-names>
</name>
, <name><surname>Pennella</surname>
<given-names>R</given-names>
</name>
, <name><surname>Everett</surname>
<given-names>MA</given-names>
</name>
, <name><surname>Fuller</surname>
<given-names>BB</given-names>
</name>
(<year>1993</year>
) <article-title>Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes</article-title>
. <source>J Invest Dermatol</source>
<volume>100</volume>
: <fpage>806</fpage>
–<lpage>811</lpage>
<pub-id pub-id-type="pmid">8496620</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Miller1"><label>56</label>
<mixed-citation publication-type="journal"><name><surname>Miller</surname>
<given-names>AJ</given-names>
</name>
, <name><surname>Tsao</surname>
<given-names>H</given-names>
</name>
(<year>2010</year>
) <article-title>New insights into pigmentary pathways and skin cancer</article-title>
. <source>Br J Dermatol</source>
<volume>162</volume>
: <fpage>22</fpage>
–<lpage>28</lpage>
<pub-id pub-id-type="pmid">19863502</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Park1"><label>57</label>
<mixed-citation publication-type="journal"><name><surname>Park</surname>
<given-names>HY</given-names>
</name>
, <name><surname>Kosmadaki</surname>
<given-names>M</given-names>
</name>
, <name><surname>Yaar</surname>
<given-names>M</given-names>
</name>
, <name><surname>Gilchrest</surname>
<given-names>BA</given-names>
</name>
(<year>2009</year>
) <article-title>Cellular mechanisms regulating human melanogenesis</article-title>
. <source>Cell Mol Life Sci</source>
<volume>66</volume>
: <fpage>1493</fpage>
–<lpage>1506</lpage>
<pub-id pub-id-type="pmid">19153661</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Cui1"><label>58</label>
<mixed-citation publication-type="journal"><name><surname>Cui</surname>
<given-names>R</given-names>
</name>
, <name><surname>Widlund</surname>
<given-names>HR</given-names>
</name>
, <name><surname>Feige</surname>
<given-names>E</given-names>
</name>
, <name><surname>Lin</surname>
<given-names>JY</given-names>
</name>
, <name><surname>Wilensky</surname>
<given-names>DL</given-names>
</name>
, <etal>et al</etal>
(<year>2007</year>
) <article-title>Central role of p53 in the suntan response and pathologic hyperpigmentation</article-title>
. <source>Cell</source>
<volume>128</volume>
: <fpage>853</fpage>
–<lpage>864</lpage>
<pub-id pub-id-type="pmid">17350573</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Verkrellis1"><label>59</label>
<mixed-citation publication-type="journal"><name><surname>Verkrellis</surname>
<given-names>K</given-names>
</name>
, <name><surname>Xilouri</surname>
<given-names>M</given-names>
</name>
, <name><surname>Emmanouilidou</surname>
<given-names>E</given-names>
</name>
, <name><surname>Rideout</surname>
<given-names>H</given-names>
</name>
, <name><surname>Stefanis</surname>
<given-names>L</given-names>
</name>
(<year>2011</year>
) <article-title>Pathological Roles of α-Syn in neurological disorders</article-title>
. <source>Lancet Neurol</source>
<volume>10</volume>
: <fpage>1015</fpage>
–<lpage>1025</lpage>
<pub-id pub-id-type="pmid">22014436</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Sulzer1"><label>60</label>
<mixed-citation publication-type="journal"><name><surname>Sulzer</surname>
<given-names>D</given-names>
</name>
, <name><surname>Bogulavsky</surname>
<given-names>J</given-names>
</name>
, <name><surname>Larsen</surname>
<given-names>KE</given-names>
</name>
, <name><surname>Behr</surname>
<given-names>G</given-names>
</name>
, <name><surname>Karatekin</surname>
<given-names>E</given-names>
</name>
, <etal>et al</etal>
(<year>2000</year>
) <article-title>Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles</article-title>
. <source>Proc Natl Acad Sci U S A</source>
<volume>97</volume>
: <fpage>11869</fpage>
–<lpage>11874</lpage>
<pub-id pub-id-type="pmid">11050221</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Xuan1"><label>61</label>
<mixed-citation publication-type="journal"><name><surname>Xuan</surname>
<given-names>Q</given-names>
</name>
, <name><surname>Xu</surname>
<given-names>SL</given-names>
</name>
, <name><surname>Lu</surname>
<given-names>DH</given-names>
</name>
, <name><surname>Yu</surname>
<given-names>S</given-names>
</name>
, <name><surname>Zhou</surname>
<given-names>M</given-names>
</name>
, <etal>et al</etal>
(<year>2011</year>
) <article-title>Increase expression of α- Syn in aged human brian associated with neuromelanin accumulation</article-title>
. <source>J Neural Transm</source>
<volume>118</volume>
: <fpage>1575</fpage>
–<lpage>1583</lpage>
<pub-id pub-id-type="pmid">21461961</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Dusek1"><label>62</label>
<mixed-citation publication-type="journal"><name><surname>Dusek</surname>
<given-names>P</given-names>
</name>
, <name><surname>Jankovic</surname>
<given-names>J</given-names>
</name>
, <name><surname>Le</surname>
<given-names>W</given-names>
</name>
(<year>2012</year>
) <article-title>Iron dysregulation in movement disorders</article-title>
. <source>Neurobiol Dis</source>
<volume>46</volume>
: <fpage>1</fpage>
–<lpage>18</lpage>
<pub-id pub-id-type="pmid">22266337</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-DeMarco1"><label>63</label>
<mixed-citation publication-type="journal"><name><surname>De Marco</surname>
<given-names>F</given-names>
</name>
, <name><surname>Foppoli</surname>
<given-names>C</given-names>
</name>
, <name><surname>Coccia</surname>
<given-names>R</given-names>
</name>
, <name><surname>Blarzino</surname>
<given-names>C</given-names>
</name>
, <name><surname>Perluigi</surname>
<given-names>M</given-names>
</name>
, <etal>et al</etal>
(<year>2004</year>
) <article-title>Ectopic deposition of melanin pigments as detoxifying mechanism: a paradigm for basal nuclei pigmentation</article-title>
. <source>Biochem Biophys Res Commun</source>
<volume>314</volume>
: <fpage>631</fpage>
–<lpage>637</lpage>
<pub-id pub-id-type="pmid">14733954</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Zecca1"><label>64</label>
<mixed-citation publication-type="journal"><name><surname>Zecca</surname>
<given-names>L</given-names>
</name>
, <name><surname>Tampellini</surname>
<given-names>D</given-names>
</name>
, <name><surname>Gatti</surname>
<given-names>A</given-names>
</name>
, <name><surname>Crippa</surname>
<given-names>R</given-names>
</name>
, <name><surname>Eisner</surname>
<given-names>M</given-names>
</name>
, <etal>et al</etal>
(<year>2002</year>
) <article-title>The neuromelanin of human substantia nigra and its interact with metals</article-title>
. <source>J Neural Transm</source>
<volume>109</volume>
: <fpage>663</fpage>
–<lpage>672</lpage>
<pub-id pub-id-type="pmid">12111458</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Enochs1"><label>65</label>
<mixed-citation publication-type="journal"><name><surname>Enochs</surname>
<given-names>WS</given-names>
</name>
, <name><surname>Sarna</surname>
<given-names>T</given-names>
</name>
, <name><surname>Zecca</surname>
<given-names>L</given-names>
</name>
, <name><surname>Riley</surname>
<given-names>PA</given-names>
</name>
, <name><surname>Swartz</surname>
<given-names>HM</given-names>
</name>
(<year>1994</year>
) <article-title>The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson’s disease: an hypothesis</article-title>
. <source>J Neural Transm Park Dis Dement Sect</source>
<volume>7</volume>
: <fpage>83</fpage>
–<lpage>100</lpage>
<pub-id pub-id-type="pmid">7710667</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Stepie1"><label>66</label>
<mixed-citation publication-type="journal"><name><surname>Stepień</surname>
<given-names>K</given-names>
</name>
, <name><surname>Dzierzega-Lecznar</surname>
<given-names>A</given-names>
</name>
, <name><surname>Tam</surname>
<given-names>I</given-names>
</name>
(<year>2007</year>
) <article-title>The role of neuromelanin in Parkinson’s disease–new concepts</article-title>
. <source>Wiad Lek</source>
<volume>60</volume>
: <fpage>563</fpage>
–<lpage>569</lpage>
<pub-id pub-id-type="pmid">18540183</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Fasano1"><label>67</label>
<mixed-citation publication-type="journal"><name><surname>Fasano</surname>
<given-names>M</given-names>
</name>
, <name><surname>Bergamasco</surname>
<given-names>B</given-names>
</name>
, <name><surname>Lopiano</surname>
<given-names>L</given-names>
</name>
(<year>2006</year>
) <article-title>Modifications of the iron-neuromelamin system in Parkinson’s disease</article-title>
. <source>J Neurochem</source>
<volume>96</volume>
: <fpage>909</fpage>
–<lpage>916</lpage>
<pub-id pub-id-type="pmid">16417570</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Zecca2"><label>68</label>
<mixed-citation publication-type="journal"><name><surname>Zecca</surname>
<given-names>L</given-names>
</name>
, <name><surname>Zucca</surname>
<given-names>FA</given-names>
</name>
, <name><surname>Albertini</surname>
<given-names>A</given-names>
</name>
, <name><surname>Rizzio</surname>
<given-names>E</given-names>
</name>
, <name><surname>Fariello</surname>
<given-names>RG</given-names>
</name>
(<year>2006</year>
) <article-title>A proposed dual role of neuromelanin in the pathogenesis of Parkinson’s disease</article-title>
. <source>Neurology</source>
<volume>67(7</volume>
Suppl 2)<fpage>S8</fpage>
–<lpage>11</lpage>
<pub-id pub-id-type="pmid">17030740</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Nicolaus1"><label>69</label>
<mixed-citation publication-type="journal"><name><surname>Nicolaus</surname>
<given-names>BJ</given-names>
</name>
(<year>2005</year>
) <article-title>A critical review of the function of neuromelanin and an attempt to provide a unified theory</article-title>
. <source>Med Hypotheses</source>
<volume>65</volume>
: <fpage>791</fpage>
–<lpage>796</lpage>
<pub-id pub-id-type="pmid">15949901</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Li1"><label>70</label>
<mixed-citation publication-type="journal"><name><surname>Li</surname>
<given-names>J</given-names>
</name>
, <name><surname>Yang</surname>
<given-names>J</given-names>
</name>
, <name><surname>Zhao</surname>
<given-names>P</given-names>
</name>
, <name><surname>Li</surname>
<given-names>S</given-names>
</name>
, <name><surname>Zhang</surname>
<given-names>R</given-names>
</name>
, <etal>et al</etal>
(<year>2012</year>
) <article-title>Neuromelanin enhances the toxicity of α-Syn in SK-N-SH cells</article-title>
. <source>J Neural Transm</source>
<volume>119</volume>
: <fpage>685</fpage>
–<lpage>691</lpage>
<pub-id pub-id-type="pmid">22200858</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Xu1"><label>71</label>
<mixed-citation publication-type="journal"><name><surname>Xu</surname>
<given-names>J</given-names>
</name>
, <name><surname>Kao</surname>
<given-names>SY</given-names>
</name>
, <name><surname>Lee</surname>
<given-names>FJ</given-names>
</name>
, <name><surname>Song</surname>
<given-names>W</given-names>
</name>
, <name><surname>Jin</surname>
<given-names>LW</given-names>
</name>
, <etal>et al</etal>
(<year>2002</year>
) <article-title>Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease</article-title>
. <source>Nat Med</source>
<volume>8</volume>
: <fpage>600</fpage>
–<lpage>606</lpage>
<pub-id pub-id-type="pmid">12042811</pub-id>
</mixed-citation>
</ref>
<ref id="pone.0045183-Ando2"><label>72</label>
<mixed-citation publication-type="journal"><name><surname>Ando</surname>
<given-names>H</given-names>
</name>
, <name><surname>Funasaka</surname>
<given-names>Y</given-names>
</name>
, <name><surname>Oka</surname>
<given-names>M</given-names>
</name>
, <name><surname>Ohashi</surname>
<given-names>A</given-names>
</name>
, <name><surname>Furumura</surname>
<given-names>M</given-names>
</name>
, <etal>et al</etal>
(<year>1999</year>
) <article-title>Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis</article-title>
. <source>J Lipid Res</source>
<volume>40</volume>
: <fpage>1312</fpage>
–<lpage>1316</lpage>
<pub-id pub-id-type="pmid">10393216</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</pmc>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
<settlement><li>Houston</li>
</settlement>
<orgName><li>Baylor College of Medicine</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Pan, Tianhong" sort="Pan, Tianhong" uniqKey="Pan T" first="Tianhong" last="Pan">Tianhong Pan</name>
</region>
<name sortKey="Hwu, Wen Jen" sort="Hwu, Wen Jen" uniqKey="Hwu W" first="Wen" last="Hwu">Wen Hwu</name>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<name sortKey="Zhu, Julie" sort="Zhu, Julie" uniqKey="Zhu J" first="Julie" last="Zhu">Julie Zhu</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000093 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000093 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:3446957 |texte= The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:23028833" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
![]() | This area was generated with Dilib version V0.6.19. | ![]() |